Andrew Lees

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Magnetic Resonance Imaging

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Silveira-Moriyama Laura; González Ana Marcos; O'Sullivan Sean S; Williams David R; Massey Luke; Parkkinen Laura; Ahmed Zeshan; de Silva Rohan; Chacón Jose R; Revesz Tamas; Lees Andrew J; Holton Janice L
Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?
Selikhova M; Williams D R; Kempster P A; Holton J L; Revesz T; Lees A J
A clinico-pathological study of subtypes in Parkinson's disease.
Kumaran Ravindran; Vandrovcova Jana; Luk Connie; Sharma Simone; Renton Alan; Wood Nicholas W; Hardy John A; Lees Andrew J; Bandopadhyay Rina
Differential DJ-1 gene expression in Parkinson's disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Andrew Lees (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Silveira-Moriyama Laura; González Ana Marcos; O'Sullivan Sean S; Williams David R; Massey Luke; Parkkinen Laura; Ahmed Zeshan; de Silva Rohan; Chacón Jose R; Revesz Tamas; Lees Andrew J; Holton Janice L
Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?
Neuroscience letters 2009;467(3):208-11.
2009: Selikhova M; Williams D R; Kempster P A; Holton J L; Revesz T; Lees A J
A clinico-pathological study of subtypes in Parkinson's disease.
Brain : a journal of neurology 2009;132(Pt 11):2947-57.
2009: Kumaran Ravindran; Vandrovcova Jana; Luk Connie; Sharma Simone; Renton Alan; Wood Nicholas W; Hardy John A; Lees Andrew J; Bandopadhyay Rina
Differential DJ-1 gene expression in Parkinson's disease.
Neurobiology of disease 2009;36(2):393-400.
2009: Lim Shen-Yang; O'Sullivan Sean S; Kotschet Katya; Gallagher David A; Lacey Cameron; Lawrence Andrew D; Lees Andrew J; O'Sullivan Dudley J; Peppard Richard F; Rodrigues Julian P; Schrag Anette; Silberstein Paul; Tisch Stephen; Evans Andrew H
Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2009;16(9):1148-52.
2009: Davidson Yvonne; Amin Hanan; Kelley Thomas; Shi Jing; Tian Jinzhou; Kumaran Ravindran; Lashley Tammaryn; Lees Andrew J; DuPlessis Daniel; Neary David; Snowden Julie; Akiyama Haruhiko; Arai Tetsuaki; Hasegawa Masato; Bandopadhyay Rina; Sikkink Steve; Pickering-Brown Stuart; Mann David M A
TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing.
Acta neuropathologica 2009;118(3):359-69.
2009: Vandrovcova Jana; Pittman Alan M; Malzer Elke; Abou-Sleiman Patrick M; Lees Andrew J; Wood Nicholas W; de Silva Rohan
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Neurobiology of aging 2009;30(9):1477-82.
2009: Neumann Juliane; Bras Jose; Deas Emma; O'Sullivan Sean S; Parkkinen Laura; Lachmann Robin H; Li Abi; Holton Janice; Guerreiro Rita; Paudel Reema; Segarane Badmavady; Singleton Andrew; Lees Andrew; Hardy John; Houlden Henry; Revesz Tamas; Wood Nicholas W
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
Brain : a journal of neurology 2009;132(Pt 7):1783-94.
2009: Silveira-Moriyama L; Schwingenschuh P; O'Donnell A; Schneider S A; Mir P; Carrillo F; Terranova C; Petrie A; Grosset D G; Quinn N P; Bhatia K P; Lees A J
Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).
Journal of neurology, neurosurgery, and psychiatry 2009;80(7):744-8.
2009: Lees Andrew J; Hardy John; Revesz Tamas
Parkinson's disease.
Lancet 2009;373(9680):2055-66.
2009: Sleiman P M A; Healy D G; Muqit M M K; Yang Y X; Van Der Brug M; Holton J L; Revesz T; Quinn N P; Bhatia K; Diss J K J; Lees A J; Cookson M R; Latchman D S; Wood N W
Characterisation of a novel NR4A2 mutation in Parkinson's disease brain.
Neuroscience letters 2009;457(2):75-9.
2009: Hardy John; Lewis Patrick; Revesz Tamas; Lees Andrew; Paisan-Ruiz Coro
The genetics of Parkinson's syndromes: a critical review.
Current opinion in genetics & development 2009;19(3):254-65.
2009: Silveira-Moriyama Laura; Sirisena Dharshana; Gamage Pasan; Gamage Ranjanie; de Silva Rohan; Lees Andrew J
Adapting the Sniffin' Sticks to diagnose Parkinson's disease in Sri Lanka.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1229-33.
2009: Silveira-Moriyama Laura; Petrie Aviva; Williams David R; Evans Andrew; Katzenschlager Regina; Barbosa Egberto R; Lees Andrew J
The use of a color coded probability scale to interpret smell tests in suspected parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1144-53.
2009: Healy Daniel G; Bressman Susan; Dickson John; Silveira-Moriyama Laura; Schneider Susanne A; Sullivan Sean S O; Massey Luke; Bhatia Kailash P; Shaw Karen; Bhatia Kailash P; Bomanji Jamshed; Wood Nicholas W; Lees Andrew J
Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1245-7.
2009: Silveira-Moriyama L; Mathias C; Mason L; Best C; Quinn N P; Lees A J
Hyposmia in pure autonomic failure.
Neurology 2009;72(19):1677-81.
2009: Luk Connie; Giovannoni Gavin; Williams David R; Lees Andrew J; de Silva Rohan
Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
Journal of neuroscience methods 2009;180(1):34-42.
2009: Silveira-Moriyama Laura; Holton Janice L; Kingsbury Ann; Ayling Hilary; Petrie Aviva; Sterlacci William; Poewe Werner; Maier Hans; Lees Andrew J; Revesz Tamas
Regional differences in the severity of Lewy body pathology across the olfactory cortex.
Neuroscience letters 2009;453(2):77-80.
2009: Camargos Sarah Teixeira; Dornas Leonardo Oliveira; Momeni Parastoo; Lees Andrew; Hardy John; Singleton Andrew; Cardoso Francisco
Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):662-6.
2009: Grosset Donald; Antonini Angelo; Canesi Margherita; Pezzoli Gianni; Lees Andrew; Shaw Karen; Cubo Esther; Martinez-Martin Pablo; Rascol Olivier; Negre-Pages Laurence; Senard Ana; Schwarz Johannes; Strecker Karl; Reichmann Heinz; Storch Alexander; Löhle Matthias; Stocchi Fabrizio; Grosset Katherine
Adherence to antiparkinson medication in a multicenter European study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(6):826-32.
2009: Segarane B; Li A; Paudel R; Scholz S; Neumann J; Lees A; Revesz T; Hardy J; Mathias C J; Wood N W; Holton J; Houlden H
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy.
Neurology 2009;72(13):1185-6.
2009: Williams David R; Lees Andrew J
Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.
Lancet neurology 2009;8(3):270-9.
2009: Blackinton Jeff; Kumaran Ravindran; van der Brug Marcel P; Ahmad Rili; Olson Lars; Galter Dagmar; Lees Andrew; Bandopadhyay Rina; Cookson Mark R
Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease.
Neuroscience letters 2009;452(1):8-11.
2009: Evans A H; Lawrence A D; Lees A J
Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2009;80(3):267-72.
2009: Momeni Parastoo; Pittman Alan; Lashley Tammaryn; Vandrovcova Jana; Malzer Elke; Luk Connie; Hulette Christine; Lees Andrew; Revesz Tamas; Hardy John; de Silva Rohan
Clinical and pathological features of an Alzheimer's disease patient with the MAPT DeltaK280 mutation.
Neurobiology of aging 2009;30(3):388-93.
2009: Lees Andrew J
The Parkinson chimera.
Neurology 2009;72(7 Suppl):S2-11.
2009: Parkkinen Laura; Silveira-Moriyama Laura; Holton Janice L; Lees Andrew J; Revesz Tamas
Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders".
Acta neuropathologica 2009;117(2):213-4; author reply 217-8.
2009: Poltawski Leon; Edwards Hazel; Todd Amy; Watson Tim; Lees Andrew; James Cherry Ann
Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(1):115-8.
2009: Williams D R; Lees A J
How do patients with parkinsonism present? A clinicopathological study.
Internal medicine journal 2009;39(1):7-12.
2009: de Teixeira Antonio Lúcio; Cardoso Francisco; Maia Débora P; Sacramento Daniel R; Mota Cleonice de Carvalho Coelho; Meira Zilda Maria Alves; Lees Andrew
Frequency and significance of vocalizations in Sydenham's chorea.
Parkinsonism & related disorders 2009;15(1):62-3.
2009: O'Sullivan Sean S; Evans Andrew H; Lees Andrew J
Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
CNS drugs 2009;23(2):157-70.
2008: Silveira-Moriyama Laura; Carvalho Margarete de Jesus; Katzenschlager Regina; Petrie Aviva; Ranvaud Ronald; Barbosa Egberto Reis; Lees Andrew J
The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil.
Movement disorders : official journal of the Movement Disorder Society 2008;23(16):2328-34.
2008: Goetz Christopher G; Tilley Barbara C; Shaftman Stephanie R; Stebbins Glenn T; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stern Matthew B; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; van Hilten Jacobus J; LaPelle Nancy;
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2129-70.
2008: Selikhova Marianna; Fedoryshyn Ljuda; Matviyenko Yuri; Komnatska Irena; Kyrylchuk Marianna; Krolicki Lesrek; Friedman Andrzej; Taylor Andrew; Jäger H Rolf; Lees Andrew; Sanotsky Yanush
Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2224-31.
2008: Gallagher D A; Lees A J; Schrag A
Unified Parkinson's Disease Rating Scale (UPDRS) part I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
Parkinsonism & related disorders 2008;14(7):586-7.
2008: Lashley T; Revesz T; Plant G; Bandopadhyay R; Lees A J; Frangione B; Wood N W; de Silva R; Ghiso J; Rostagno A; Holton J L
Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease.
Neuropathology and applied neurobiology 2008;34(5):492-505.
2008: Silveira-Moriyama L; Guedes L C; Kingsbury A; Ayling H; Shaw K; Barbosa E R; Bonifati V; Quinn N P; Abou-Sleiman P; Wood N W; Petrie A; Sampaio C; Ferreira J J; Holton J; Revesz T; Lees A J
Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.
Neurology 2008;71(13):1021-6.
2008: Gilman S; Wenning G K; Low P A; Brooks D J; Mathias C J; Trojanowski J Q; Wood N W; Colosimo C; Dürr A; Fowler C J; Kaufmann H; Klockgether T; Lees A; Poewe W; Quinn N; Revesz T; Robertson D; Sandroni P; Seppi K; Vidailhet M
Second consensus statement on the diagnosis of multiple system atrophy.
Neurology 2008;71(9):670-6.
2008: Katzenschlager R; Head J; Schrag A; Ben-Shlomo Y; Evans A; Lees A J;
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.
Neurology 2008;71(7):474-80.
2008: Healy Daniel G; Falchi Mario; O'Sullivan Sean S; Bonifati Vincenzo; Durr Alexandra; Bressman Susan; Brice Alexis; Aasly Jan; Zabetian Cyrus P; Goldwurm Stefano; Ferreira Joaquim J; Tolosa Eduardo; Kay Denise M; Klein Christine; Williams David R; Marras Connie; Lang Anthony E; Wszolek Zbigniew K; Berciano Jose; Schapira Anthony H V; Lynch Timothy; Bhatia Kailash P; Gasser Thomas; Lees Andrew J; Wood Nicholas W;
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Lancet neurology 2008;7(7):583-90.
2008: Kovacs Gabor G; Pittman Alan; Revesz Tamas; Luk Connie; Lees Andrew; Kiss Eva; Tariska Peter; Laszlo Lajos; Molnár Kinga; Molnar Maria J; Tolnay Markus; de Silva Rohan
MAPT S305I mutation: implications for argyrophilic grain disease.
Acta neuropathologica 2008;116(1):103-18.
2008: Williams D R; Warren J D; Lees A J
Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 2008;79(6):652-5.
2008: Rascol Olivier; Poewe Werner; Lees Andrew; Aristin Marina; Salin Laurence; Juhel Nolwenn; Waldhauser Lisa; Schindler Thomas;
Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.
Archives of neurology 2008;65(5):577-83.
2008: Li Jia-Yi; Englund Elisabet; Holton Janice L; Soulet Denis; Hagell Peter; Lees Andrew J; Lashley Tammaryn; Quinn Niall P; Rehncrona Stig; Björklund Anders; Widner Håkan; Revesz Tamas; Lindvall Olle; Brundin Patrik
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
Nature medicine 2008;14(5):501-3.
2008: O'Sullivan S S; Massey L A; Williams D R; Silveira-Moriyama L; Kempster P A; Holton J L; Revesz T; Lees A J
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
Brain : a journal of neurology 2008;131(Pt 5):1362-72.
2008: Williams David R; Doyle Louise M F; Lees Andrew J; Brown Peter
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
Journal of neurology 2008;255(5):628-32.
2008: Warren Naomi M; Piggott Margaret A; Lees Andrew J; Perry Elaine K; Burn David J
Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.
Journal of chemical neuroanatomy 2008;35(3):268-74.
2008: Wolters Erik; Lees Andrew J; Volkmann Jens; van Laar Teus; Hovestadt Ad
Managing Parkinson's disease with continuous dopaminergic stimulation.
CNS spectrums 2008;13(4 Suppl 7):1-14; quiz 15-6.
2008: Lees Andrew J; Selikhova Marianna; Andrade Luiz Augusto; Duyckaerts Charles
The black stuff and Konstantin Nikolaevich Tretiakoff.
Movement disorders : official journal of the Movement Disorder Society 2008;23(6):777-83.
2008: Lashley Tammaryn; Holton Janice L; Gray Emma; Kirkham Konrad; O'Sullivan Sean S; Hilbig Arlete; Wood Nicholas W; Lees Andrew J; Revesz Tamas
Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients.
Acta neuropathologica 2008;115(4):417-25.
2008: Camargos Sarah; Scholz Sonja; Simón-Sánchez Javier; Paisán-Ruiz Coro; Lewis Patrick; Hernandez Dena; Ding Jinhui; Gibbs J Raphael; Cookson Mark R; Bras Jose; Guerreiro Rita; Oliveira Catarina Resende; Lees Andrew; Hardy John; Cardoso Francisco; Singleton Andrew B
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
Lancet neurology 2008;7(3):207-15.
2008: Holton J L; Schneider S A; Ganesharajah T; Gandhi S; Strand C; Shashidharan P; Barreto J; Wood N W; Lees A J; Bhatia K P; Revesz T
Neuropathology of primary adult-onset dystonia.
Neurology 2008;70(9):695-9.
2008: Williams David R; Lees Andrew J; Wherrett John R; Steele John C
J. Clifford Richardson and 50 years of progressive supranuclear palsy.
Neurology 2008;70(7):566-73.
2008: O'Sullivan S S; Holton J L; Massey L A; Williams D R; Revesz T; Lees A J
Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 2008;79(2):232-4.
2008: Rosenkranz K; Butler K; Williamon A; Cordivari C; Lees A J; Rothwell J C
Sensorimotor reorganization by proprioceptive training in musician's dystonia and writer's cramp.
Neurology 2008;70(4):304-15.
2008: Camargos Sarah Teixeira; Cardoso Francisco; Momeni Parastoo; Gianetti Juliana Gurgel; Lees Andrew; Hardy John; Singleton Andrew
Novel GCH1 mutation in a Brazilian family with dopa-responsive dystonia.
Movement disorders : official journal of the Movement Disorder Society 2008;23(2):299-302.
2008: O'Sullivan Sean S; Williams David R; Gallagher David A; Massey Luke A; Silveira-Moriyama Laura; Lees Andrew J
Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study.
Movement disorders : official journal of the Movement Disorder Society 2008;23(1):101-6.
2008: Olanow C Warren; Lees Andrew; Obeso Jose
Levodopa therapy for Parkinson's disease: challenges and future prospects.
Movement disorders : official journal of the Movement Disorder Society 2008;23 Suppl 3():S495-6.
2008: Lees Andrew J
Evidence-based efficacy comparison of tolcapone and entacapone as adjunctive therapy in Parkinson's disease.
CNS neuroscience & therapeutics 2008;14(1):83-93.
2008: Blomstedt Patric; Hariz Marwan I; Lees Andrew; Silberstein Paul; Limousin Patricia; Yelnik Jérôme; Agid Yves
Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report.
Parkinsonism & related disorders 2008;14(3):253-6.
2007: Dubois Bruno; Burn David; Goetz Christopher; Aarsland Dag; Brown Richard G; Broe Gerald A; Dickson Dennis; Duyckaerts Charles; Cummings Jefferey; Gauthier Serge; Korczyn Amos; Lees Andrew; Levy Richard; Litvan Irene; Mizuno Yoshikuni; McKeith Ian G; Olanow C Warren; Poewe Werner; Sampaio Cristina; Tolosa Eduardo; Emre Murat
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2314-24.
2007: O'Sullivan Sean S; Evans Andrew H; Lees Andrew J
Punding in Parkinson's disease.
Practical neurology 2007;7(6):397-9.
2007: Williams David R; Holton Janice L; Strand Kate; Revesz Tamas; Lees Andrew J
Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(15):2235-41.
2007: Omar R; Warren J D; Ron M A; Lees A J; Rossor M N; Kartsounis L D
The neuro-behavioural syndrome of brainstem disease.
Neurocase : case studies in neuropsychology, neuropsychiatry, and behavioural neurology 2007;13(5):452-65.
2007: Kumaran Ravindran; Kingsbury Ann; Coulter Ian; Lashley Tammaryn; Williams David; de Silva Rohan; Mann David; Revesz Tamas; Lees Andrew; Bandopadhyay Rina
DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.
Neurobiology of disease 2007;28(1):122-32.
2007: Lees Andrew J
Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday.
Movement disorders : official journal of the Movement Disorder Society 2007;22 Suppl 17():S327-34.
2007: Gallagher David A; O'Sullivan Sean S; Evans Andrew H; Lees Andrew J; Schrag Anette
Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.
Movement disorders : official journal of the Movement Disorder Society 2007;22(12):1757-63.
2007: Emre Murat; Aarsland Dag; Brown Richard; Burn David J; Duyckaerts Charles; Mizuno Yoshikino; Broe Gerald Anthony; Cummings Jeffrey; Dickson Dennis W; Gauthier Serge; Goldman Jennifer; Goetz Christopher; Korczyn Amos; Lees Andrew; Levy Richard; Litvan Irene; McKeith Ian; Olanow Warren; Poewe Werner; Quinn Niall; Sampaio Christina; Tolosa Eduardo; Dubois Bruno
Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(12):1689-707; quiz 1837.
2007: Lees A J; Ratziu V; Tolosa E; Oertel W H
Safety and tolerability of adjunctive tolcapone treatment in patients with early Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(9):944-8.
2007: Katzenschlager R; Schrag A; Evans A; Manson A; Carroll C B; Ottaviani D; Lees A J; Hobart J
Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure.
Neurology 2007;69(6):555-63.
2007: Kempster P A; Williams D R; Selikhova M; Holton J; Revesz T; Lees A J
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study.
Brain : a journal of neurology 2007;130(Pt 8):2123-8.
2007: Warren Naomi M; Piggott Margaret A; Greally Elizabeth; Lake Michelle; Lees Andrew J; Burn David J
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(11):1594-600.
2007: Kempster Peter A; Hurwitz Brian; Lees Andrew J
A new look at James Parkinson's Essay on the Shaking Palsy.
Neurology 2007;69(5):482-5.
2007: Abuirmeileh Amjad; Lever Rebecca; Kingsbury Ann E; Lees Andrew J; Locke Ian C; Knight Richard A; Chowdrey Hardial S; Biggs Christopher S; Whitton Peter S
The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.
The European journal of neuroscience 2007;26(2):417-23.
2007: Scherfler Christoph; Schwarz Johannes; Antonini Angelo; Grosset Donald; Valldeoriola Francesc; Marek Kenneth; Oertel Wolfgang; Tolosa Eduardo; Lees Andrew J; Poewe Werner
Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1229-38.
2007: Zijlmans Jan; Evans Andrew; Fontes Flavia; Katzenschlager Regina; Gacinovic Svetoslav; Lees Andrew J; Costa Durval
[123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1278-85.
2007: Williams David R; Holton Janice L; Strand Catherine; Pittman Alan; de Silva Rohan; Lees Andrew J; Revesz Tamas
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
Brain : a journal of neurology 2007;130(Pt 6):1566-76.
2007: Ravina Bernard; Marder Karen; Fernandez Hubert H; Friedman Joseph H; McDonald William; Murphy Diane; Aarsland Dag; Babcock Debra; Cummings Jefferey; Endicott Jean; Factor Stewart; Galpern Wendy; Lees Andrew; Marsh Laura; Stacy Mark; Gwinn-Hardy Katrina; Voon Valerie; Goetz Christopher
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
Movement disorders : official journal of the Movement Disorder Society 2007;22(8):1061-8.
2007: Warren N M; Piggott M A; Lees A J; Burn D J
The basal ganglia cholinergic neurochemistry of progressive supranuclear palsy and other neurodegenerative diseases.
Journal of neurology, neurosurgery, and psychiatry 2007;78(6):571-5.
2007: Lees Andrew J; Singleton Andrew B
Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation.
Neurology 2007;68(19):1553-4.
2007: Warren Naomi M; Piggott Margaret A; Lees Andrew J; Burn David J
Muscarinic receptors in the thalamus in progressive supranuclear palsy and other neurodegenerative disorders.
Journal of neuropathology and experimental neurology 2007;66(5):399-404.
2007: O'Sullivan Sean S; Lees Andrew J
Pathological gambling in Parkinson's disease.
Lancet neurology 2007;6(5):384-6.
2007: Paviour Dominic C; Price Shona L; Lees Andrew J; Fox Nick C
MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects.
Journal of neurology 2007;254(4):478-81.
2007: Katzenschlager Regina; Jackson Michael J; Rose Sarah; Stockwell Kim; Tayarani-Binazir Kayhan A; Zubair Mohammed; Smith Lance A; Jenner Peter; Lees Andrew J
Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
Movement disorders : official journal of the Movement Disorder Society 2007;22(5):715-9.
2007: Williams David R; Pittman Alan M; Revesz Tamas; Lees Andrew J; de Silva Rohan
Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(6):895-7.
2007: Myers Amanda J; Pittman Alan M; Zhao Alice S; Rohrer Kristen; Kaleem Mona; Marlowe Lauren; Lees Andrew; Leung Doris; McKeith Ian G; Perry Robert H; Morris Chris M; Trojanowski John Q; Clark Christopher; Karlawish Jason; Arnold Steve; Forman Mark S; Van Deerlin Vivianna; de Silva Rohan; Hardy John
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.
Neurobiology of disease 2007;25(3):561-70.
2007: Oda Tatsuro; Tsuchiya Kuniaki; Arai Tetsuaki; Togo Takashi; Uchikado Hirotake; de Silva Rohan; Lees Andrew; Akiyama Haruhiko; Haga Chie; Ikeda Kenji; Kato Motoichiro; Kato Yuji; Hara Tsunekatsu; Onaya Mitsumoto; Hori Koji; Teramoto Hiroshi; Tominaga Itaru
Pick's disease with Pick bodies: an unusual autopsy case showing degeneration of the pontine nucleus, dentate nucleus, Clarke's column, and lower motor neuron.
Neuropathology : official journal of the Japanese Society of Neuropathology 2007;27(1):81-9.
2007: Aarsland D; Emre M; Lees A; Poewe W; Ballard C
Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology 2007;68(1):80; author reply 81.
2007: Goetz Christopher G; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stebbins Glenn T; Stern Matthew B; Tilley Barbara C; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; Van Hilten Jacobus J; LaPelle Nancy
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):41-7.
2007: Paviour Dominic C; Thornton John S; Lees Andrew J; Jäger H Rolf
Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):68-74.
2007: Hanagasi Hasmet Ayhan; Lees Andrew; Johnson Janel O; Singleton Andrew; Emre Murat
Smoking-responsive juvenile-onset Parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):115-9.
2007: Burn David J; Lees Andrew J
Progressive supranuclear palsy.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():327-49.
2006: Rascol Olivier; Dubois Bruno; Caldas Alexandre Castro; Senn Stephen; Del Signore Susanna; Lees Andrew;
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2110-5.
2006: Silveira-Moriyama Laura; Evans Andrew H; Katzenschlager Regina; Lees Andrew J
Punding and dyskinesias.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2214-7.
2006: Paviour Dominic C; Jäger H Rolf; Wilkinson Leonora; Jahanshahi Marjan; Lees Andrew J
Holmes tremor: Application of modern neuroimaging techniques.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2260-2.
2006: Pineda-Trujillo Nicolas; Apergi Maria; Moreno Sonia; Arias William; Lesage Suzanne; Franco Alejandro; Sepulveda-Falla Diego; Cano David; Buriticá Omar; Pineda David; Uribe Carlos Santiago; de Yebenes Justo Garcia; Lees Andrew J; Brice Alexis; Bedoya Gabriel; Lopera Francisco; Ruiz-Linares Andres
A genetic cluster of early onset Parkinson's disease in a Colombian population.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2006;141B(8):885-9.
2006: Pavese N; Evans A H; Tai Y F; Hotton G; Brooks D J; Lees A J; Piccini P
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.
Neurology 2006;67(9):1612-7.
2006: Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen J P; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C;
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(11):1186-202.
2006: Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen J P; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C;
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(11):1170-85.
2006: Yokota Osamu; Tsuchiya Kuniaki; Oda Tatsurou; Ishihara Takeshi; de Silva Rohan; Lees Andrew J; Arai Tetsuaki; Uchihara Toshiki; Ishizu Hideki; Kuroda Shigetoshi; Akiyama Haruhiko
Amyotrophic lateral sclerosis with dementia: an autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration.
Acta neuropathologica 2006;112(5):633-45.
2006: Healy Daniel G; Abou-Sleiman Patrick M; Ahmadi Kourosh R; Gandhi Sonia; Muqit Miratul M; Bhatia Kailash P; Quinn Niall P; Lees Andrew J; Holton Janice L; Revesz Tamas; Wood Nicholas W
NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1960-3.
2006: Abou-Sleiman Patrick M; Muqit Miratul M K; McDonald Neil Q; Yang Yan Xiang; Gandhi Sonia; Healy Daniel G; Harvey Kirsten; Harvey Robert J; Deas Emma; Bhatia Kailash; Quinn Niall; Lees Andrew; Latchman David S; Wood Nicholas W
A heterozygous effect for PINK1 mutations in Parkinson's disease?
Annals of neurology 2006;60(4):414-9.
2006: Cordivari Carla; Misra Vijay Peter; Vincent Angela; Catania Santiago; Bhatia Kailash P; Lees Andrew John
Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1737-41.
2006: Ingelsson Martin; Ramasamy Karunya; Cantuti-Castelvetri Ippolita; Skoglund Lena; Matsui Toshifumi; Orne Jennifer; Kowa Hasimoto; Raju Susan; Vanderburg Charles R; Augustinack Jean C; de Silva Rohan; Lees Andrew J; Lannfelt Lars; Growdon John H; Frosch Matthew P; Standaert David G; Irizarry Michael C; Hyman Bradley T
No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain.
Acta neuropathologica 2006;112(4):439-49.
2006: Shaw-Smith Charles; Pittman Alan M; Willatt Lionel; Martin Howard; Rickman Lisa; Gribble Susan; Curley Rebecca; Cumming Sally; Dunn Carolyn; Kalaitzopoulos Dimitrios; Porter Keith; Prigmore Elena; Krepischi-Santos Ana C V; Varela Monica C; Koiffmann Celia P; Lees Andrew J; Rosenberg Carla; Firth Helen V; de Silva Rohan; Carter Nigel P
Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability.
Nature genetics 2006;38(9):1032-7.
2006: Greggio Elisa; Jain Shushant; Kingsbury Ann; Bandopadhyay Rina; Lewis Patrick; Kaganovich Alice; van der Brug Marcel P; Beilina Alexandra; Blackinton Jeff; Thomas Kelly Jean; Ahmad Rili; Miller David W; Kesavapany Sashi; Singleton Andrew; Lees Andrew; Harvey Robert J; Harvey Kirsten; Cookson Mark R
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
Neurobiology of disease 2006;23(2):329-41.
2006: Muthane Uday B; Chickabasaviah Yasha T; Henderson Jasmine; Kingsbury Ann E; Kilford Linda; Shankar Susarla K; Subbakrishna D K; Lees Andrew J
Melanized nigral neuronal numbers in Nigerian and British individuals.
Movement disorders : official journal of the Movement Disorder Society 2006;21(8):1239-41.
2006: Schrag A; Selai C; Quinn N; Lees A; Litvan I; Lang A; Poon Y; Bower J; Burn D; Hobart J
Measuring quality of life in PSP: the PSP-QoL.
Neurology 2006;67(1):39-44.
2006: Muqit Miratul M K; Abou-Sleiman Patrick M; Saurin Adrian T; Harvey Kirsten; Gandhi Sonia; Deas Emma; Eaton Simon; Payne Smith Martin D; Venner Kerrie; Matilla Antoni; Healy Daniel G; Gilks William P; Lees Andrew J; Holton Janice; Revesz Tamas; Parker Peter J; Harvey Robert J; Wood Nicholas W; Latchman David S
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
Journal of neurochemistry 2006;98(1):156-69.
2006: Gandhi S; Muqit M M K; Stanyer L; Healy D G; Abou-Sleiman P M; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees A J; Latchman D S; Holton J L; Wood N W; Revesz T
PINK1 protein in normal human brain and Parkinson's disease.
Brain : a journal of neurology 2006;129(Pt 7):1720-31.
2006: Paviour Dominic C; Price Shona L; Jahanshahi Marjan; Lees Andrew J; Fox Nick C
Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
Movement disorders : official journal of the Movement Disorder Society 2006;21(7):989-96.
2006: Vogt Ina R; Lees Andrew J; Evert Bernd O; Klockgether Thomas; Bonin Michael; Wüllner Ullrich
Transcriptional changes in multiple system atrophy and Parkinson's disease putamen.
Experimental neurology 2006;199(2):465-78.
2006: Scherfler Christoph; Khan Naheed L; Pavese Nicola; Lees Andrew J; Quinn Niall P; Brooks David J; Piccini Paola P
Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
Movement disorders : official journal of the Movement Disorder Society 2006;21(6):783-8.
2006: Evans Andrew H; Pavese Nicola; Lawrence Andrew D; Tai Yen F; Appel Silke; Doder Miroslava; Brooks David J; Lees Andrew J; Piccini Paola
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Annals of neurology 2006;59(5):852-8.
2006: de Silva Rohan; Lashley Tammaryn; Strand Catherine; Shiarli Anna-Maria; Shi Jing; Tian Jinzhou; Bailey Kathryn L; Davies Peter; Bigio Eileen H; Arima Kunimasa; Iseki Eizo; Murayama Shigeo; Kretzschmar Hans; Neumann Manuela; Lippa Carol; Halliday Glenda; MacKenzie James; Ravid Rivka; Dickson Dennis; Wszolek Zbigniew; Iwatsubo Takeshi; Pickering-Brown Stuart M; Holton Janice; Lees Andrew; Revesz Tamas; Mann David M A
An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.
Acta neuropathologica 2006;111(4):329-40.
2006: Williams D R; Watt H C; Lees A J
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):468-73.
2006: Ozawa T; Healy D G; Abou-Sleiman P M; Ahmadi K R; Quinn N; Lees A J; Shaw K; Wullner U; Berciano J; Moller J C; Kamm C; Burk K; Josephs K A; Barone P; Tolosa E; Goldstein D B; Wenning G; Geser F; Holton J L; Gasser T; Revesz T; Wood N W;
The alpha-synuclein gene in multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 2006;77(4):464-7.
2006: Paviour Dominic C; Price Shona L; Jahanshahi Marjan; Lees Andrew J; Fox Nick C
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
Brain : a journal of neurology 2006;129(Pt 4):1040-9.
2006: Healy Daniel G; Abou-Sleiman Patrick M; Casas Juan P; Ahmadi Kourosh R; Lynch Timothy; Gandhi Sonia; Muqit Miratul M K; Foltynie Thomas; Barker Roger; Bhatia Kailash P; Quinn Niall P; Lees Andrew J; Gibson J Mark; Holton Janice L; Revesz Tamas; Goldstein David B; Wood Nicholas W
UCHL-1 is not a Parkinson's disease susceptibility gene.
Annals of neurology 2006;59(4):627-33.
2006: Evans A H; Lawrence A D; Potts J; MacGregor L; Katzenschlager R; Shaw K; Zijlmans J; Lees A J
Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2006;77(3):317-21.
2006: Hu Michele T M; Scherfler Christoph; Khan Naheed L; Hajnal Jo V; Lees Andrew J; Quinn Niall; Wood Nicholas W; Brooks David J
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(3):299-305.
2006: Kamphuis Daan J; Koelman Hans; Lees Andrew J; Tijssen Marina A J
Sporadic rapid-onset dystonia-parkinsonism presenting as Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):118-9.
2005: Piao Yue-Shan; Tan Chun-Feng; Iwanaga Keisuke; Kakita Akiyoshi; Takano Hiroki; Nishizawa Masatoyo; Lashley Tammaryn; Revesz Tamas; Lees Andrew; de Silva Rohan; Tsujihata Mitsuhiro; Takahashi Hitoshi
Sporadic four-repeat tauopathy with frontotemporal degeneration, parkinsonism and motor neuron disease.
Acta neuropathologica 2005;110(6):600-9.
2005: Khan Naheed L; Jain Shushant; Lynch John M; Pavese Nicola; Abou-Sleiman Patrick; Holton Janice L; Healy Daniel G; Gilks William P; Sweeney Mary G; Ganguly Milan; Gibbons Vaneesha; Gandhi Sonia; Vaughan Jenny; Eunson Louise H; Katzenschlager Regina; Gayton Juliet; Lennox Graham; Revesz Tamas; Nicholl David; Bhatia Kailash P; Quinn Niall; Brooks David; Lees Andrew J; Davis Mary B; Piccini Paola; Singleton Andrew B; Wood Nicholas W
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
Brain : a journal of neurology 2005;128(Pt 12):2786-96.
2005: McKeith I G; Dickson D W; Lowe J; Emre M; O'Brien J T; Feldman H; Cummings J; Duda J E; Lippa C; Perry E K; Aarsland D; Arai H; Ballard C G; Boeve B; Burn D J; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz C G; Gomez-Tortosa E; Halliday G; Hansen L A; Hardy J; Iwatsubo T; Kalaria R N; Kaufer D; Kenny R A; Korczyn A; Kosaka K; Lee V M Y; Lees A; Litvan I; Londos E; Lopez O L; Minoshima S; Mizuno Y; Molina J A; Mukaetova-Ladinska E B; Pasquier F; Perry R H; Schulz J B; Trojanowski J Q; Yamada M;
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology 2005;65(12):1863-72.
2005: Evans A H; Lawrence A D; Potts J; Appel S; Lees A J
Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease.
Neurology 2005;65(10):1570-4.
2005: Gioltzoglou T; Cordivari C; Lee P J; Hanna M G; Lees A J
Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature.
Journal of neurology, neurosurgery, and psychiatry 2005;76(11):1594-6.
2005: Loy Clement T; Sweeney Mary G; Davis Mary B; Wills Adrian J; Sawle Guy V; Lees Andrew J; Tabrizi Sarah J
Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging.
Movement disorders : official journal of the Movement Disorder Society 2005;20(11):1521-3.
2005: Paviour Dominic C; Williams David; Fowler Clare J; Quinn Niall P; Lees Andrew J
Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis.
Movement disorders : official journal of the Movement Disorder Society 2005;20(11):1425-30.
2005: Bandopadhyay Rina; Kingsbury Ann E; Muqit Miratul M; Harvey Kirsten; Reid Andrew R; Kilford Linda; Engelender Simone; Schlossmacher Michael G; Wood Nicholas W; Latchman David S; Harvey Robert J; Lees Andrew J
Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.
Neurobiology of disease 2005;20(2):401-11.
2005: Pittman A M; Myers A J; Abou-Sleiman P; Fung H C; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris C M; Dickson D; Wood N W; Hardy J; Lees A J; de Silva R
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
Journal of medical genetics 2005;42(11):837-46.
2005: Williams David R; Lees Andrew J
Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.
Lancet neurology 2005;4(10):605-10.
2005: Healy Daniel G; Abou-Sleiman Patrick M; Quinn Niall; Ahmadi Kourosh R; Ozawa Tetsutaro; Kamm Christoph; Wullner Ullrich; Oertel Wolfgang H; Burk Katrin; Dupont Erik; Pellecchia Maria T; Tolosa Eduardo; Gasser Thomas; Holton Janice L; Revesz Tamas; Goldstein David B; Lees Andrew J; Wood Nicholas W;
UCHL-1 gene in multiple system atrophy: a haplotype tagging approach.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1338-43.
2005: Williams David R; Hadeed Ali; al-Din Amir S Najim; Wreikat Abdel-Latif; Lees Andrew J
Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1264-71.
2005: Paviour Dominic C; Revesz Tamas; Holton Janice L; Evans Andrew; Olsson Jan-Edvin; Lees Andrew J
Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies.
Movement disorders : official journal of the Movement Disorder Society 2005;20(10):1345-9.
2005: Khan Naheed L; Giunti Paola; Sweeney Mary G; Scherfler Christoph; Brien Michael O; Piccini Paola; Wood Nicholas W; Lees Andrew J
Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).
Movement disorders : official journal of the Movement Disorder Society 2005;20(9):1115-9.
2005: Paviour D C; Winterburn D; Simmonds S; Burgess G; Wilkinson L; Fox N C; Lees A J; Jahanshahi M
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
Neurocase : case studies in neuropsychology, neuropsychiatry, and behavioural neurology 2005;11(4):274-82.
2005: Caparros-Lefebvre Dominique; Lees Andrew J
Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.
Movement disorders : official journal of the Movement Disorder Society 2005;20 Suppl 12():S114-8.
2005: Hardy John; Lees Andrew J
Parkinson's disease: a broken nosology.
Movement disorders : official journal of the Movement Disorder Society 2005;20 Suppl 12():S2-4.
2005: Neumann M; Mittelbronn M; Simon P; Vanmassenhove B; de Silva R; Lees A; Klapp J; Meyermann R; Kretzschmar H A
A new family with frontotemporal dementia with intronic 10+3 splice site mutation in the tau gene: neuropathology and molecular effects.
Neuropathology and applied neurobiology 2005;31(4):362-73.
2005: Myers A J; Kaleem M; Marlowe L; Pittman A M; Lees A J; Fung H C; Duckworth J; Leung D; Gibson A; Morris C M; de Silva R; Hardy J
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.
Human molecular genetics 2005;14(16):2399-404.
2005: Bandopadhyay Rina; Miller David W; Kingsbury Ann E; Jowett Terry P; Kaleem Mona M; Pittman Alan M; de Silva Rohan; Cookson Mark R; Lees Andrew J
Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein.
Neuroscience letters 2005;383(3):225-30.
2005: Colosimo Carlo; Osaki Yasushi; Vanacore Nicola; Lees Andrew J
Reply: Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study.
Movement disorders : official journal of the Movement Disorder Society 2005;20(8):1086-7.
2005: Kamm C; Healy D G; Quinn N P; Wüllner U; Moller J C; Schols L; Geser F; Burk K; Børglum A D; Pellecchia M T; Tolosa E; del Sorbo F; Nilsson C; Bandmann O; Sharma M; Mayer P; Gasteiger M; Haworth A; Ozawa T; Lees A J; Short J; Giunti P; Holinski-Feder E; Illig T; Wichmann H E; Wenning G K; Wood N W; Gasser T;
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group.
Brain : a journal of neurology 2005;128(Pt 8):1855-60.
2005: Lewerenz Jan; Zurowski Bartosz; Jenicke Lars; Bäumer Tobias; Lees Andrew J; Münchau Alexander
Lesion of the dorsorostral midbrain sparing the nigrostriatal tract mimics axial rigidity seen in progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2005;20(8):1071-5.
2005: Findley Leslie J; Lees Andrew; Apajasalo Marjo; Pitkänen Anna; Turunen Heidi
Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
Current medical research and opinion 2005;21(7):1005-14.
2005: Morris H R; Bronstein Adolfo M; Shaw Christopher E; Lees Andrew J; Love S
Clinical grand round: a rapidly progressive pyramidal and extrapyramidal syndrome with a supranuclear gaze palsy.
Movement disorders : official journal of the Movement Disorder Society 2005;20(7):826-31.
2005: Williams David R; de Silva Rohan; Paviour Dominic C; Pittman Alan; Watt Hilary C; Kilford Linda; Holton Janice L; Revesz Tamas; Lees Andrew J
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Brain : a journal of neurology 2005;128(Pt 6):1247-58.
2005: Remy Philippe; Doder Miroslava; Lees Andrew; Turjanski Nora; Brooks David
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
Brain : a journal of neurology 2005;128(Pt 6):1314-22.
2005: Nath U; Thomson R; Wood R; Ben-Shlomo Y; Lees A; Rooney C; Burn D
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Journal of neurology, neurosurgery, and psychiatry 2005;76(4):498-502.
2005: Rosenkranz Karin; Williamon Aaron; Butler Katherine; Cordivari Carla; Lees Andrew J; Rothwell John C
Pathophysiological differences between musician's dystonia and writer's cramp.
Brain : a journal of neurology 2005;128(Pt 4):918-31.
2005: Khan Naheed L; Horta Wagner; Eunson Louise; Graham Elizabeth; Johnson Janel O; Chang Shannon; Davis Mary; Singleton Andrew; Wood Nicholas W; Lees Andrew J
Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow-up over 10 years.
Movement disorders : official journal of the Movement Disorder Society 2005;20(4):479-84.
2005: Grosset Katherine; Grosset Donald; Lees Andrew;
Trial of subtherapeutic pergolide in de novo Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(3):363-6.
2005: Paviour D C; Price S L; Stevens J M; Lees A J; Fox N C
Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy.
Neurology 2005;64(4):675-9.
2005: Clarimon Jordi; Johnson Janel; Dogu Okan; Horta Wagner; Khan Naheed; Lees Andrew J; Hardy John; Singleton Andrew
Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;133B(1):120-3.
2005: Katzenschlager Regina; Hughes Andrew; Evans Andrew; Manson Alice J; Hoffman Marion; Swinn Lesley; Watt Hilary; Bhatia Kailash; Quinn Niall; Lees Andrew J
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
Movement disorders : official journal of the Movement Disorder Society 2005;20(2):151-7.
2005: Gilks William P; Abou-Sleiman Patrick M; Gandhi Sonia; Jain Shushant; Singleton Andrew; Lees Andrew J; Shaw Karen; Bhatia Kailash P; Bonifati Vincenzo; Quinn Niall P; Lynch John; Healy Daniel G; Holton Janice L; Revesz Tamas; Wood Nicholas W
A common LRRK2 mutation in idiopathic Parkinson's disease.
Lancet 2005;365(9457):415-6.
2005: Khan N L; Scherfler C; Graham E; Bhatia K P; Quinn N; Lees A J; Brooks D J; Wood N W; Piccini P
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Neurology 2005;64(1):134-6.
2005: Grosset D G; Lees A J
Long duration asymmetric postural tremor in the development of Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2005;76(1):9.
2005: Serrien Deborah J; Orth Michael; Evans Andrew H; Lees Andrew J; Brown Peter
Motor inhibition in patients with Gilles de la Tourette syndrome: functional activation patterns as revealed by EEG coherence.
Brain : a journal of neurology 2005;128(Pt 1):116-25.
2005: Lees Andrew
Alternatives to levodopa in the initial treatment of early Parkinson's disease.
Drugs & aging 2005;22(9):731-40.
2004: Morris Huw R; Steele John C; Crook Richard; Wavrant-De Vrièze Fabienne; Onstead-Cardinale Luisa; Gwinn-Hardy Katrina; Wood Nick W; Farrer Matthew; Lees Andrew J; McGeer P L; Siddique Teepu; Hardy John; Perez-Tur Jordi
Genome-wide analysis of the parkinsonism-dementia complex of Guam.
Archives of neurology 2004;61(12):1889-97.
2004: Emre Murat; Aarsland Dag; Albanese Alberto; Byrne E Jane; Deuschl Günther; De Deyn Peter P; Durif Franck; Kulisevsky Jaime; van Laar Teus; Lees Andrew; Poewe Werner; Robillard Alain; Rosa Mario M; Wolters Erik; Quarg Peter; Tekin Sibel; Lane Roger
Rivastigmine for dementia associated with Parkinson's disease.
The New England journal of medicine 2004;351(24):2509-18.
2004: Bearn Jennifer; Evans Andrew; Kelleher Michael; Turner Kirsten; Lees Andrew
Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study.
Drug and alcohol dependence 2004;76(3):305-10.
2004: Paviour D C; Schott J M; Stevens J M; Revesz T; Holton J L; Rossor M N; Lees A J; Fox N C
Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 2004;75(12):1772-5.
2004: Katzenschlager R; Zijlmans J; Evans A; Watt H; Lees A J
Olfactory function distinguishes vascular parkinsonism from Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(12):1749-52.
2004: Katzenschlager R; Evans A; Manson A; Patsalos P N; Ratnaraj N; Watt H; Timmermann L; Van der Giessen R; Lees A J
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
Journal of neurology, neurosurgery, and psychiatry 2004;75(12):1672-7.
2004: Ozawa Tetsutaro; Paviour Dominic; Quinn Niall P; Josephs Keith A; Sangha Hardev; Kilford Linda; Healy Daniel G; Wood Nick W; Lees Andrew J; Holton Janice L; Revesz Tamas
The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.
Brain : a journal of neurology 2004;127(Pt 12):2657-71.
2004: Paisán-Ruíz Coro; Jain Shushant; Evans E Whitney; Gilks William P; Simón Javier; van der Brug Marcel; López de Munain Adolfo; Aparicio Silvia; Gil Angel Martínez; Khan Naheed; Johnson Janel; Martinez Javier Ruiz; Nicholl David; Carrera Itxaso Marti; Pena Amets Saénz; de Silva Rohan; Lees Andrew; Martí-Massó José Félix; Pérez-Tur Jordi; Wood Nick W; Singleton Andrew B
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
Neuron 2004;44(4):595-600.
2004: Paviour D C; Lees A J; Josephs K A; Ozawa T; Ganguly M; Strand C; Godbolt A; Howard R S; Revesz T; Holton J L
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy.
Brain : a journal of neurology 2004;127(Pt 11):2441-51.
2004: Price Shona; Paviour Dominic; Scahill Rachael; Stevens John; Rossor Martin; Lees Andrew; Fox Nick
Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease.
NeuroImage 2004;23(2):663-9.
2004: Schott Jonathan M; Lees Andrew J; Rossor Martin N
Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathology.
Annals of neurology 2004;56(4):604; author reply 604.
2004: Edwards Mark J; Dale Russell C; Church Andrew J; Trikouli Eleni; Quinn Niall P; Lees Andrew J; Giovannoni Gavin; Bhatia Kailash P
Adult-onset tic disorder, motor stereotypies, and behavioural disturbance associated with antibasal ganglia antibodies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(10):1190-6.
2004: Evans Andrew H; Costa Durval C; Gacinovic Sveto; Katzenschlager Regina; O'sullivan John D; Heales Simon; Lee Phillip; Lees Andrew J
L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings.
Movement disorders : official journal of the Movement Disorder Society 2004;19(10):1232-6.
2004: Zijlmans Jan C M; Debilly Berengere; Rascol Olivier; Lees Andrew J; Durif Franck
Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):1006-1011.
2004: Healy Daniel G; Abou-Sleiman Patrick M; Ahmadi Kourosh R; Muqit Miratul M K; Bhatia Kailash P; Quinn Niall P; Lees Andrew J; Latchmann David S; Goldstein David B; Wood Nicholas W
The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism.
Annals of neurology 2004;56(3):329-35.
2004: Page R A; Davie C A; MacManus D; Miszkiel K A; Walshe J M; Miller D H; Lees A J; Schapira A H V
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease.
Neurology 2004;63(4):638-43.
2004: Katzenschlager Regina; Lees Andrew J
Olfaction and Parkinson's syndromes: its role in differential diagnosis.
Current opinion in neurology 2004;17(4):417-23.
2004: Evans Andrew H; Lees Andrew J
Dopamine dysregulation syndrome in Parkinson's disease.
Current opinion in neurology 2004;17(4):393-8.
2004: Gerschlager Willibald; Münchau Alexander; Katzenschlager Regina; Brown Peter; Rothwell John C; Quinn Niall; Lees Andrew J; Bhatia Kailash P
Natural history and syndromic associations of orthostatic tremor: a review of 41 patients.
Movement disorders : official journal of the Movement Disorder Society 2004;19(7):788-95.
2004: Grosse Pascal; Edwards M; Tijssen M A J; Schrag A; Lees Andrew J; Bhatia K P; Brown Peter
Patterns of EMG-EMG coherence in limb dystonia.
Movement disorders : official journal of the Movement Disorder Society 2004;19(7):758-69.
2004: Edwards M J; Trikouli E; Martino D; Bozi M; Dale R C; Church A J; Schrag A; Lees A J; Quinn N P; Giovannoni G; Bhatia K P
Anti-basal ganglia antibodies in patients with atypical dystonia and tics: a prospective study.
Neurology 2004;63(1):156-8.
2004: Healy D G; Abou-Sleiman P M; Lees A J; Casas J P; Quinn N; Bhatia K; Hingorani A D; Wood N W
Tau gene and Parkinson's disease: a case-control study and meta-analysis.
Journal of neurology, neurosurgery, and psychiatry 2004;75(7):962-5.
2004: Evans Andrew H; Gacinovic Sveto; Costa Durval C; Lees Andrew J
Parkinsonism due to Kernohan notch: clinical, structural, and functional imaging correlates.
Neurology 2004;62(12):2333-4.
2004: Zijlmans Jan C M; Daniel Susan E; Hughes Andrew J; Révész Tamas; Lees Andrew J
Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):630-40.
2004: Pittman Alan M; Myers Amanda J; Duckworth Jaime; Bryden Leslie; Hanson Melissa; Abou-Sleiman Patrick; Wood Nicholas W; Hardy John; Lees Andrew; de Silva Rohan
The structure of the tau haplotype in controls and in progressive supranuclear palsy.
Human molecular genetics 2004;13(12):1267-74.
2004: Scherfler Christoph; Khan Naheed L; Pavese Nicola; Eunson Louise; Graham Elizabeth; Lees Andrew J; Quinn Niall P; Wood Nicholas W; Brooks David J; Piccini Paola P
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Brain : a journal of neurology 2004;127(Pt 6):1332-42.
2004: Togo Takashi; Akiyama Haruhiko; Iseki Eizo; Uchikado Hirotake; Kondo Hiromi; Ikeda Kenji; Tsuchiya Kuniaki; de Silva Rohan; Lees Andrew; Kosaka Kenji
Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
Acta neuropathologica 2004;107(6):504-8.
2004: Khan N L; Katzenschlager R; Watt H; Bhatia K P; Wood N W; Quinn N; Lees A J
Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease.
Neurology 2004;62(7):1224-6.
2004: Evans Andrew H; Katzenschlager Regina; Paviour Dominic; O'Sullivan John D; Appel Silke; Lawrence Andrew D; Lees Andrew J
Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
Movement disorders : official journal of the Movement Disorder Society 2004;19(4):397-405.
2004: Hope Andrew D; Lashley Tammaryn; Lees Andrew J; de Silva Rohan
Failure in heat-shock protein expression in response to UBB+1 protein in progressive supranuclear palsy in humans.
Neuroscience letters 2004;359(1-2):94-8.
2004: Zijlmans J C M; Katzenschlager R; Daniel S E; Lees A J L
The L-dopa response in vascular parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 2004;75(4):545-7.
2004: Cordivari Carla; Misra V Peter; Catania Santiago; Lees Andrew J
New therapeutic indications for botulinum toxins.
Movement disorders : official journal of the Movement Disorder Society 2004;19 Suppl 8():S157-61.
2004: Healy Daniel G; Abou-Sleiman Patrick M; Ozawa Tetsutaro; Lees Andrew J; Bhatia Kailash; Ahmadi Kourosh R; Wullner Ullrich; Berciano Jose; Moller J Carsten; Kamm Christoph; Burk Katrin; Barone Paolo; Tolosa Eduardo; Quinn Niall; Goldstein David B; Wood Nicholas W;
A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.
Annals of neurology 2004;55(3):443-6.
2004: Osaki Yasushi; Ben-Shlomo Yoav; Lees Andrew J; Daniel Susan E; Colosimo Carlo; Wenning Gregor; Quinn Niall
Accuracy of clinical diagnosis of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2004;19(2):181-9.
2004: Kingsbury Ann E; Daniel Susan E; Sangha Hardev; Eisen Sarah; Lees Andrew J; Foster Oliver J F
Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2004;19(2):162-70.
2004: Paviour Dominic C; Surtees Robert A H; Lees Andrew J
Diagnostic considerations in juvenile parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2004;19(2):123-35.
2004: Gibb G M; de Silva R; Revesz T; Lees A J; Anderton B H; Hanger D P
Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy.
Brain research. Molecular brain research 2004;121(1-2):95-101.
2004: Katzenschlager R; Manson A J; Evans A; Watt H; Lees A J
Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.
Journal of neurology, neurosurgery, and psychiatry 2004;75(2):295-7.
2004: Serra-Mestres J; Ring H A; Costa D C; Gacinovic S; Walker Z; Lees A J; Robertson M M; Trimble M R
Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study.
Acta psychiatrica Scandinavica 2004;109(2):140-6.
2004: Bandopadhyay Rina; Kingsbury Ann E; Cookson Mark R; Reid Andrew R; Evans Ian M; Hope Andrew D; Pittman Alan M; Lashley Tammaryn; Canet-Aviles Rosa; Miller David W; McLendon Chris; Strand Catherine; Leonard Andrew J; Abou-Sleiman Patrick M; Healy Daniel G; Ariga Hiroyashi; Wood Nicholas W; de Silva Rohan; Revesz Tamas; Hardy John A; Lees Andrew J
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
Brain : a journal of neurology 2004;127(Pt 2):420-30.
2004: de Silva Rohan; Lashley Tammaryn; Revesz Tamas; Lees Andrew; Powers James M
Detecting tau isoforms in archival cases.
Acta neuropathologica 2004;107(2):181-2.
2004: Healy D G; Abou-Sleiman P M; Valente E M; Gilks W P; Bhatia K; Quinn N; Lees A J; Wood N W
DJ-1 mutations in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(1):144-5.
2004: Dale Russell C; Church Andrew J; Surtees Robert A H; Lees Andrew J; Adcock Jane E; Harding Brian; Neville Brian G R; Giovannoni Gavin
Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
Brain : a journal of neurology 2004;127(Pt 1):21-33.
2003: Schrag Anette; Selai Caroline; Davis Jennifer; Lees Andrew J; Jahanshahi Marjan; Quinn Niall
Health-related quality of life in patients with progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2003;18(12):1464-9.
2003: Swinn Lesley; Schrag Anette; Viswanathan Ramchandran; Bloem Bastiaan R; Lees Andrew; Quinn Niall
Sweating dysfunction in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(12):1459-63.
2003: Katzenschlager Regina; Cardozo Adriana; Avila Cobo M Rosario; Tolosa Eduardo; Lees Andrew J
Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders.
Movement disorders : official journal of the Movement Disorder Society 2003;18(10):1123-31.
2003: Lees Andrew J; Grosset Donald G
Dopamine transporter imaging.
Movement disorders : official journal of the Movement Disorder Society 2003;18 Suppl 7():S1-2.
2003: Lawrence Andrew D; Evans Andrew H; Lees Andrew J
Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?
Lancet neurology 2003;2(10):595-604.
2003: Hogg Marion; Grujic Zoran M; Baker Matt; Demirci Serpil; Guillozet Angela L; Sweet Alison P; Herzog Laura L; Weintraub Sandra; Mesulam M-Marsel; LaPointe Nichole E; Gamblin T C; Berry Robert W; Binder Lester I; de Silva Rohan; Lees Andrew; Espinoza Marisol; Davies Peter; Grover Andrew; Sahara Naruhiko; Ishizawa Takashi; Dickson Dennis; Yen Shu-Hui; Hutton Michael; Bigio Eileen H
The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Acta neuropathologica 2003;106(4):323-36.
2003: Lees Andrew J
Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Movement disorders : official journal of the Movement Disorder Society 2003;18 Suppl 6():S28-33.
2003: Abou-Sleiman Patrick M; Healy Daniel G; Quinn Niall; Lees Andrew J; Wood Nicholas W
The role of pathogenic DJ-1 mutations in Parkinson's disease.
Annals of neurology 2003;54(3):283-6.
2003: Katsuse Omi; Iseki Eizo; Arai Tetsuaki; Akiyama Haruhiko; Togo Takashi; Uchikado Hirotake; Kato Masanori; de Silva Rohan; Lees Andrew; Kosaka Kenji
4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
Acta neuropathologica 2003;106(3):251-60.
2003: de Silva R; Hope A; Pittman A; Weale M E; Morris H R; Wood N W; Lees A J
Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy.
Neurology 2003;61(3):407-9.
2003: Perry Elaine K; Kilford Linda; Lees Andrew J; Burn David J; Perry Robert H
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs.
Annals of neurology 2003;54(2):235-8.
2003: Hope Andrew D; de Silva Rohan; Fischer David F; Hol Elly M; van Leeuwen Fred W; Lees Andrew J
Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression.
Journal of neurochemistry 2003;86(2):394-404.
2003: Morris H R; Osaki Y; Holton J; Lees A J; Wood N W; Revesz T; Quinn N
Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP.
Neurology 2003;61(1):102-4.
2003: Seemungal Barry M; Faldon Mary; Revesz Tamas; Lees Andrew J; Zee David S; Bronstein Adolfo M
Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2003;18(7):818-22.
2003: Colosimo C; Hughes A J; Kilford L; Lees A J
Lewy body cortical involvement may not always predict dementia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2003;74(7):852-6.
2003: Gibson G E; Kingsbury A E; Xu H; Lindsay J G; Daniel S; Foster O J F; Lees A J; Blass J P
Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease.
Neurochemistry international 2003;43(2):129-35.
2003: Schwarz M J; Houghton P J; Rose S; Jenner P; Lees A D
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.
Pharmacology, biochemistry, and behavior 2003;75(3):627-33.
2003: de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
Neuropathology and applied neurobiology 2003;29(3):288-302.
2003: Colosimo Carlo; Osaki Yasushi; Vanacore Nicola; Lees Andrew J
Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study.
Movement disorders : official journal of the Movement Disorder Society 2003;18(6):694-7.
2003: Khan Naheed L; Graham Elizabeth; Critchley Peter; Schrag Anette E; Wood Nicholas W; Lees Andrew J; Bhatia Kailash P; Quinn Niall
Parkin disease: a phenotypic study of a large case series.
Brain : a journal of neurology 2003;126(Pt 6):1279-92.
2003: Church A J; Dale R C; Lees A J; Giovannoni G; Robertson M M
Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.
Journal of neurology, neurosurgery, and psychiatry 2003;74(5):602-7.
2003: Katzenschlager Regina; Costa Durval; Gerschlager Willibald; O'Sullivan John; Zijlmans Jan; Gacinovic Svetoslav; Pirker Walter; Wills Adrian; Bhatia Kailash; Lees Andrew J; Brown Peter
[123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor.
Annals of neurology 2003;53(4):489-96.
2003: Nath U; Ben-Shlomo Y; Thomson R G; Lees A J; Burn D J
Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study.
Neurology 2003;60(6):910-6.
2003: Weeks Robert A; Scaravilli Francisco; Lees Andrew J; Carroll Camille; Husain Masud; Rudge Peter
Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):331-6.
2003: Church Andrew J; Dale Russell C; Cardoso Francisco; Candler Paul M; Chapman Miles D; Allen Meredith L; Klein Nigel J; Lees Andrew J; Giovannoni Gavin
CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?
Journal of neuroimmunology 2003;136(1-2):149-53.
2003: Iseki Eizo; Togo Takashi; Suzuki Kyoko; Katsuse Omi; Marui Wami; de Silva Rohan; Lees Andrews; Yamamoto Takayuki; Kosaka Kenji
Dementia with Lewy bodies from the perspective of tauopathy.
Acta neuropathologica 2003;105(3):265-70.
2003: Doder M; Rabiner E A; Turjanski N; Lees A J; Brooks D J;
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study.
Neurology 2003;60(4):601-5.
2003: Gerschlager W; Katzenschlager R; Schrag A; Lees A J; Brown P; Quinn N; Bhatia K P
Quality of life in patients with orthostatic tremor.
Journal of neurology 2003;250(2):212-5.
2003: Katzenschlager R; Sampaio C; Costa J; Lees A
Anticholinergics for symptomatic management of Parkinson's disease.
Cochrane database of systematic reviews (Online) 2003;(2):CD003735.
2002: Katzenschlager Regina; Costa Durval; Gacinovic Svetislav; Lees Andrew J
[(123)I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia.
Neurology 2002;59(12):1974-6.
2002: Lees A J
Drugs for Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2002;73(6):607-10.
2002: Manson Alice J; Turner Kirsten; Lees Andrew J
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
Movement disorders : official journal of the Movement Disorder Society 2002;17(6):1235-41.
2002: Hanger D P; Gibb G M; de Silva R; Boutajangout A; Brion J-P; Revesz T; Lees A J; Anderton B H
The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies.
FEBS letters 2002;531(3):538-42.
2002: Burn David J; Lees Andrew J
Progressive supranuclear palsy: where are we now?
Lancet neurology 2002;1(6):359-69.
2002: Khan Naheed L; Brooks David J; Pavese Nicola; Sweeney Mary G; Wood Nicholas W; Lees Andrew J; Piccini Paola
Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
Brain : a journal of neurology 2002;125(Pt 10):2248-56.
2002: Steele John C; Caparros-Lefebvre Dominique; Lees Andrew J; Sacks Oliver W
Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
Parkinsonism & related disorders 2002;9(1):39-54.
2002: Katzenschlager Regina; Lees Andrew J
Treatment of Parkinson's disease: levodopa as the first choice.
Journal of neurology 2002;249 Suppl 2():II19-24.
2002: Zijlmans Jan; Booij Jan; Valk Jaap; Lees Andrew; Horstink Martin
Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway.
Movement disorders : official journal of the Movement Disorder Society 2002;17(5):1086-8.
2002: Cordivari Carla; Lees Andrew J; Misra V Peter; Brown Peter
EMG-EMG coherence in writer's cramp.
Movement disorders : official journal of the Movement Disorder Society 2002;17(5):1011-6.
2002: de Silva Rohan; Hardy John; Crook Julia; Khan Naheed; Graham Elizabeth A; Morris Christopher M; Wood Nicholas W; Lees Andrew J
The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease.
Neuroscience letters 2002;330(2):201-3.
2002: Morris H R; Baker M; Yasojima K; Houlden H; Khan M N; Wood N W; Hardy J; Grossman M; Trojanowski J; Revesz T; Bigio E H; Bergeron C; Janssen J C; McGeer P L; Rossor M N; Lees A J; Lantos P L; Hutton M
Analysis of tau haplotypes in Pick's disease.
Neurology 2002;59(3):443-5.
2002: Utton Michelle A; Connell James; Asuni Ayodeji A; van Slegtenhorst Marjon; Hutton Michael; de Silva Rohan; Lees Andrew J; Miller Chris C J; Anderton Brian H
The slow axonal transport of the microtubule-associated protein tau and the transport rates of different isoforms and mutants in cultured neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(15):6394-400.
2002: Eapen Valsamma; Lees Andrew J; Lakke J P W F; Trimble Michael R; Robertson Mary M
Adult-onset tic disorders.
Movement disorders : official journal of the Movement Disorder Society 2002;17(4):735-40.
2002: Dale Russell C; Church Andrew J; Benton Sarah; Surtees Robert A; Lees Andrew; Thompson Edward J; Giovannoni Gavin; Neville Brian G
Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis.
Developmental medicine and child neurology 2002;44(7):485-9.
2002: Church A J; Cardoso F; Dale R C; Lees A J; Thompson E J; Giovannoni G
Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea.
Neurology 2002;59(2):227-31.
2002: Togo Takashi; Sahara Naruhiko; Yen Shu-Hui; Cookson Natalie; Ishizawa Takashi; Hutton Mike; de Silva Rohan; Lees Andrew; Dickson Dennis W
Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
Journal of neuropathology and experimental neurology 2002;61(6):547-56.
2002: Tijssen Marina A J; Münchau Alex; Marsden John F; Lees Andrew; Bhatia Kailash P; Brown Peter
Descending control of muscles in patients with cervical dystonia.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):493-500.
2002: Morris H R; Gibb G; Katzenschlager R; Wood N W; Hanger D P; Strand C; Lashley T; Daniel S E; Lees A J; Anderton B H; Revesz T
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
Brain : a journal of neurology 2002;125(Pt 5):969-75.
2002: Hughes Andrew J; Daniel Susan E; Ben-Shlomo Yoav; Lees Andrew J
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.
Brain : a journal of neurology 2002;125(Pt 4):861-70.
2002: Caparros-Lefebvre Dominique; Sergeant Nicolas; Lees Andrew; Camuzat Agnes; Daniel Susan; Lannuzel Annie; Brice Alexis; Tolosa Eduardo; Delacourte Andre; Duyckaerts Charles
Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Brain : a journal of neurology 2002;125(Pt 4):801-11.
2002: O'Sullivan John D; Rothwell John; Lees Andrew J; Brown Peter
Bilaterally coherent tremor resembling enhanced physiological tremor: report of three cases.
Movement disorders : official journal of the Movement Disorder Society 2002;17(2):387-91.
2002: Lees Andrew J
Odd and unusual movement disorders.
Journal of neurology, neurosurgery, and psychiatry 2002;72 Suppl 1():I17-I21.
2002: Morris H R; Katzenschlager R; Janssen J C; Brown J M; Ozansoy M; Quinn N; Revesz T; Rossor M N; Daniel S E; Wood N W; Lees A J
Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 2002;72(3):388-90.
2002: Rowe James; Stephan Klaas Enno; Friston Karl; Frackowiak Richard; Lees Andrew; Passingham Richard
Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions.
Brain : a journal of neurology 2002;125(Pt 2):276-89.
2001: Hughes A J; Ben-Shlomo Y; Daniel S E; Lees A J
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. 1992.
Neurology 2001;57(10 Suppl 3):S34-8.
2001: Bostantjopoulou S; Katsarou Z; Papadimitriou A; Veletza V; Hatzigeorgiou G; Lees A
Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation.
Movement disorders : official journal of the Movement Disorder Society 2001;16(6):1007-13.
2001: Piccini P; de Yebenez J; Lees A J; Ceravolo R; Turjanski N; Pramstaller P; Brooks D J
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Archives of neurology 2001;58(11):1846-51.
2001: Morris H R; Khan M N; Janssen J C; Brown J M; Perez-Tur J; Baker M; Ozansoy M; Hardy J; Hutton M; Wood N W; Lees A J; Revesz T; Lantos P; Rossor M N
The genetic and pathological classification of familial frontotemporal dementia.
Archives of neurology 2001;58(11):1813-6.
2001: Pirtosek Z; Jahanshahi M; Barrett G; Lees A J
Attention and cognition in bradykinetic-rigid syndromes: an event-related potential study.
Annals of neurology 2001;50(5):567-73.
2001: Lees A J; Katzenschlager R; Head J; Ben-Shlomo Y
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial.
Neurology 2001;57(9):1687-94.
2001: Morris H R; Al-Sarraj S; Schwab C; Gwinn-Hardy K; Perez-Tur J; Wood N W; Hardy J; Lees A J; McGeer P L; Daniel S E; Steele J C
A clinical and pathological study of motor neurone disease on Guam.
Brain : a journal of neurology 2001;124(Pt 11):2215-22.
2001: Hughes A J; Daniel S E; Lees A J
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.
Neurology 2001;57(8):1497-9.
2001: Morris H R; Schrag A; Nath U; Burn D; Quinn N P; Daniel S; Wood N W; Lees A J
Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.
Neuroscience letters 2001;312(2):118-20.
2001: de Silva R; Weiler M; Morris H R; Martin E R; Wood N W; Lees A J
Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy.
Neuroscience letters 2001;311(3):145-8.
2001: Cordivari C; Misra V P; Catania S; Lees A J
Treatment of dystonic clenched fist with botulinum toxin.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):907-13.
2001: Koller W; Lees A; Doder M; Hely M;
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations.
Movement disorders : official journal of the Movement Disorder Society 2001;16(5):858-66.
2001: Ben-Shlomo Y; Lees A;
Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
Neurology 2001;57(2):369; author reply 369-70.
2001: Bandopadhyay R; de Silva R; Khan N; Graham E; Vaughan J; Engelender S; Ross C; Morris H; Morris C; Wood N W; Daniel S; Lees A
No pathogenic mutations in the synphilin-1 gene in Parkinson's disease.
Neuroscience letters 2001;307(2):125-7.
2001: Nath U; Ben-Shlomo Y; Thomson R G; Morris H R; Wood N W; Lees A J; Burn D J
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.
Brain : a journal of neurology 2001;124(Pt 7):1438-49.
2001: Houlden H; Baker M; Morris H R; MacDonald N; Pickering-Brown S; Adamson J; Lees A J; Rossor M N; Quinn N P; Kertesz A; Khan M N; Hardy J; Lantos P L; St George-Hyslop P; Munoz D G; Mann D; Lang A E; Bergeron C; Bigio E H; Litvan I; Bhatia K P; Dickson D; Wood N W; Hutton M
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.
Neurology 2001;56(12):1702-6.
2001: Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Annals of neurology 2001;49(5):665-8.
2001: Münchau A; Palmer J D; Dressler D; O'Sullivan J D; Tsang K L; Jahanshahi M; Quinn N P; Lees A J; Bhatia K P
Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.
Brain : a journal of neurology 2001;124(Pt 4):769-83.
2001: Manson A J; Katzenschlager R; Hobart J; Lees A J
High dose naltrexone for dyskinesias induced by levodopa.
Journal of neurology, neurosurgery, and psychiatry 2001;70(4):554-6.
2001: Manson A J; Hanagasi H; Turner K; Patsalos P N; Carey P; Ratnaraj N; Lees A J
Intravenous apomorphine therapy in Parkinson's disease: clinical and pharmacokinetic observations.
Brain : a journal of neurology 2001;124(Pt 2):331-40.
2001: O'Sullivan J D; Brown P; Lees A J
Unusual tremor associated with a posterolateral thalamic lesion in a drummer.
Movement disorders : official journal of the Movement Disorder Society 2001;16(1):174-6.
2001: O'Sullivan J D; Costa D C; Gacinovic S; Lees A J
SPECT imaging of the dopamine transporter in juvenile-onset dystonia.
Neurology 2001;56(2):266-7.
2001: Münchau A; Bahlke G; Allen P J; Quinn N P; Lees A J; Rothwell J C; Palmer J D; Bhatia K P
Polymyography combined with time-locked video recording (video EMG) for presurgical assessment of patients with cervical dystonia.
European neurology 2001;45(4):222-8.
2001: Marks L; Turner K; O'Sullivan J; Deighton B; Lees A
Drooling in Parkinson's disease: a novel speech and language therapy intervention.
International journal of language & communication disorders / Royal College of Speech & Language Therapists 2001;36 Suppl():282-7.
2000: Morris H R; Vaughan J R; Datta S R; Bandopadhyay R; Rohan De Silva H A; Schrag A; Cairns N J; Burn D; Nath U; Lantos P L; Daniel S; Lees A J; Quinn N P; Wood N W
Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE.
Neurology 2000;55(12):1918-20.
2000: O'Sullivan J D; Lees A J
Nonparkinsonian tremors.
Clinical neuropharmacology 2000;23(5):233-8.
2000: O'Sullivan J D; Hanagasi H A; Daniel S E; Tidswell P; Davies S W; Lees A J
Neuronal intranuclear inclusion disease and juvenile parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2000;15(5):990-5.
2000: Manson A J; Schrag A; Lees A J
Low-dose olanzapine for levodopa induced dyskinesias.
Neurology 2000;55(6):795-9.
2000: O'Sullivan J D; Bhatia K P; Lees A J
Botulinum toxin A as treatment for drooling saliva in PD.
Neurology 2000;55(4):606-7.
2000: Kimber J; Mathias C J; Lees A J; Bleasdale-Barr K; Chang H S; Churchyard A; Watson L
Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy.
Brain : a journal of neurology 2000;123 ( Pt 7)():1422-30.
2000: Benamer T S; Patterson J; Grosset D G; Booij J; de Bruin K; van Royen E; Speelman J D; Horstink M H; Sips H J; Dierckx R A; Versijpt J; Decoo D; Van Der Linden C; Hadley D M; Doder M; Lees A J; Costa D C; Gacinovic S; Oertel W H; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):503-10.
2000: Chawda S J; Münchau A; Johnson D; Bhatia K; Quinn N P; Stevens J; Lees A J; Palmer J D
Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation.
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):465-71.
2000: Wenning G K; Ben-Shlomo Y; Hughes A; Daniel S E; Lees A; Quinn N P
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):434-40.
2000: Giovannoni G; O'Sullivan J D; Turner K; Manson A J; Lees A J
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):423-8.
2000: Manson A J; Iakovidou E; Lees A J
Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):336-7.
2000: Morris H R; Thacker A J; Newman P K; Lees A J
Sign language tics in a prelingually deaf man.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):318-20.
2000: Schrag A; Good C D; Miszkiel K; Morris H R; Mathias C J; Lees A J; Quinn N P
Differentiation of atypical parkinsonian syndromes with routine MRI.
Neurology 2000;54(3):697-702.
2000: Manson A J; Brown P; O'Sullivan J D; Asselman P; Buckwell D; Lees A J
An ambulatory dyskinesia monitor.
Journal of neurology, neurosurgery, and psychiatry 2000;68(2):196-201.
1999: Tijssen M A; Brown P; Morris H R; Lees A
Late onset startle induced tics.
Journal of neurology, neurosurgery, and psychiatry 1999;67(6):782-4.
1999: O'Sullivan J D; Lees A J
Use of apomorphine in Parkinson's disease.
Hospital medicine (London, England : 1998) 1999;60(11):816-20.
1999: Agid Y; Ahlskog E; Albanese A; Calne D; Chase T; De Yebenes J; Factor S; Fahn S; Gershanik O; Goetz C; Koller W; Kurth M; Lang A; Lees A; Lewitt P; Marsden D; Melamed E; Michel P P; Mizuno Y; Obeso J; Oertel W; Olanow W; Poewe W; Pollak P; Tolosa E
Levodopa in the treatment of Parkinson's disease: a consensus meeting.
Movement disorders : official journal of the Movement Disorder Society 1999;14(6):911-3.
1999: Giovannoni G; van Schalkwyk J; Fritz V U; Lees A J
Bradykinesia akinesia inco-ordination test (BRAIN TEST): an objective computerised assessment of upper limb motor function.
Journal of neurology, neurosurgery, and psychiatry 1999;67(5):624-9.
1999: Morris H R; Wood N W; Lees A J
Progressive supranuclear palsy (Steele-Richardson-Olszewski disease).
Postgraduate medical journal 1999;75(888):579-84.
1999: Steele J C; Morris H R; Lees A J; Perez-Tur J; McGeer P L
Atypical parkinsonism in the French West Indies.
Lancet 1999;354(9188):1474.
1999: Schrag A; Samuel M; Caputo E; Scaravilli T; Troyer M; Marsden C D; Thomas D G; Lees A J; Brooks D J; Quinn N P
Unilateral pallidotomy for Parkinson's disease: results after more than 1 year.
Journal of neurology, neurosurgery, and psychiatry 1999;67(4):511-7.
1999: Morris H R; Lees A J; Wood N W
Neurofibrillary tangle parkinsonian disorders--tau pathology and tau genetics.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):731-6.
1999: Rojo A; Pernaute R S; Fontán A; Ruíz P G; Honnorat J; Lynch T; Chin S; Gonzalo I; Rábano A; Martínez A; Daniel S; Pramstaller P; Morris H; Wood N; Lees A; Tabernero C; Nyggard T; Jackson A C; Hanson A; de Yébenes J G;
Clinical genetics of familial progressive supranuclear palsy.
Brain : a journal of neurology 1999;122 ( Pt 7)():1233-45.
1999: Morris H R; Lees A J
Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):530-2.
1999: Merello M; Lees A J; Balej J; Cammarota A; Leiguarda R
GPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine.
Movement disorders : official journal of the Movement Disorder Society 1999;14(3):481-3.
1999: Morris H R; Janssen J C; Bandmann O; Daniel S E; Rossor M N; Lees A J; Wood N W
The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
Journal of neurology, neurosurgery, and psychiatry 1999;66(5):665-7.
1999: Wang H C; Lees A J; Brown P
Impairment of EEG desynchronisation before and during movement and its relation to bradykinesia in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1999;66(4):442-6.
1999: Turjanski N; Lees A J; Brooks D J
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Neurology 1999;52(5):932-7.
1999: Churchyard A; Mathias C J; Lees A J
Selegiline-induced postural hypotension in Parkinson's disease: a longitudinal study on the effects of drug withdrawal.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):246-51.
1999: Doder M; Jahanshahi M; Turjanski N; Moseley I F; Lees A J
Parkinson's syndrome after closed head injury: a single case report.
Journal of neurology, neurosurgery, and psychiatry 1999;66(3):380-5.
1999: Morris H R; Perez-Tur J; Janssen J C; Brown J; Lees A J; Wood N W; Hardy J; Hutton M; Rossor M N
Mutation in the tau exon 10 splice site region in familial frontotemporal dementia.
Annals of neurology 1999;45(2):270-1.
1999: O'Sullivan J D; Lees A J; Hughes A J
Yawning in Parkinson's disease.
Neurology 1999;52(2):428.
1999: Ben-Shlomo Y; Head J; Lees A J
Mortality in DATATOP.
Annals of neurology 1999;45(1):138-9.
1999: Litvan I; Lees A J
Progressive supranuclear palsy.
Advances in neurology 1999;80():341-5.
1998: Eve D J; Nisbet A P; Kingsbury A E; Hewson E L; Daniel S E; Lees A J; Marsden C D; Foster O J
Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease.
Brain research. Molecular brain research 1998;63(1):62-71.
1998: Spencer J P; Jenner P; Daniel S E; Lees A J; Marsden D C; Halliwell B
Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Journal of neurochemistry 1998;71(5):2112-22.
1998: Head J; Ben-Shlomo Y; Lees A J
Reply to Jack E. Riggs' "Deprenyl, excess mortality, and epidemiological traps". Parkinson's Disease Research Group of the United Kingdom.
Clinical neuropharmacology 1998;21(4):265-6.
1998: Rascol O; Sieradzan K; Peyro-Saint-Paul H; Thalamas C; Brefel-Courbon C; Senard J M; Ladure P; Montastruc J L; Lees A
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):673-6.
1998: Schrag A; Kingsley D; Phatouros C; Mathias C J; Lees A J; Daniel S E; Quinn N P
Clinical usefulness of magnetic resonance imaging in multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 1998;65(1):65-71.
1998: Morris H R; Moriabadi N F; Lees A J; Dick D J; Turjanski D
Parkinsonism following electrical injury to the hand.
Movement disorders : official journal of the Movement Disorder Society 1998;13(3):600-2.
1998: Houser M K; Sheean G L; Lees A J
Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
Journal of neurology, neurosurgery, and psychiatry 1998;64(5):577-80.
1998: Colzi A; Turner K; Lees A J
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1998;64(5):573-6.
1998: Ben-Shlomo Y; Churchyard A; Head J; Hurwitz B; Overstall P; Ockelford J; Lees A J
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
BMJ (Clinical research ed.) 1998;316(7139):1191-6.
1998: Acland K M; Churchyard A; Fletcher C L; Turner K; Lees A; Dowd P M
Panniculitis in association with apomorphine infusion.
The British journal of dermatology 1998;138(3):480-2.
1998: Brooks D J; Abbott R J; Lees A J; Martignoni E; Philcox D V; Rascol O; Roos R A; Sagar H J
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.
Clinical neuropharmacology 1998;21(2):101-7.
1998: Colosimo C; Merello M; Hughes A J; Sieradzan K; Lees A J
Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.
Neurology 1998;50(2):573-4.
1998: Samuel M; Caputo E; Brooks D J; Schrag A; Scaravilli T; Branston N M; Rothwell J C; Marsden C D; Thomas D G; Lees A J; Quinn N P
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.
Brain : a journal of neurology 1998;121 ( Pt 1)():59-75.
1998: Lees A J
Catechol-0-methyl transferase inhibitors in the treatment of Parkinson's disease.
Neurología (Barcelona, Spain) 1998;13 Suppl 1():72-5.
1997: Churchyard A; Lees A J
The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease.
Neurology 1997;49(6):1570-6.
1997: Turjanski N; Pentland B; Lees A J; Brooks D J
Parkinsonism associated with acute intracranial hematomas: an [18F]dopa positron-emission tomography study.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1035-8.
1997: Brown P; Rothwell J C; Stevens J M; Lees A J; Marsden C D
Cerebellar axial postural tremor.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):977-84.
1997: Lees A J
Trauma and Parkinson disease.
Revue neurologique 1997;153(10):541-6.
1997: Davie C A; Barker G J; Machado C; Miller D H; Lees A J
Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):767-71.
1997: Turjanski N; Lees A J; Brooks D J
In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.
Neurology 1997;49(3):717-23.
1997: Alam Z I; Daniel S E; Lees A J; Marsden D C; Jenner P; Halliwell B
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.
Journal of neurochemistry 1997;69(3):1326-9.
1997: Alam Z I; Jenner A; Daniel S E; Lees A J; Cairns N; Marsden C D; Jenner P; Halliwell B
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.
Journal of neurochemistry 1997;69(3):1196-203.
1997: Churchyard A; Mathias C J; Boonkongchuen P; Lees A J
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;63(2):228-34.
1997: Turjanski N; Lees A J; Brooks D J
Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET study.
Neurology 1997;49(1):183-9.
1997: Bisdorff A R; Bronstein A M; Wolsley C; Lees A J
Torticollis due to disinhibition of the vestibulo-collic reflex in a patient with Steele-Richardson-Olszewski syndrome.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):328-36.
1997: Hestnes A; Daniel S E; Lees A J; Brun A
Down's syndrome and Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;62(3):289.
1997: Lees A J; Head J; Shlomo Y B
Selegiline and mortality in Parkinson's disease: another view.
Annals of neurology 1997;41(2):282-3.
1997: Piccini P; Morrish P K; Turjanski N; Sawle G V; Burn D J; Weeks R A; Mark M H; Maraganore D M; Lees A J; Brooks D J
Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study.
Annals of neurology 1997;41(2):222-9.
1997: Cairns N J; Atkinson P F; Kovács T; Lees A J; Daniel S E; Lantos P L
Apolipoprotein E e4 allele frequency in patients with multiple system atrophy.
Neuroscience letters 1997;221(2-3):161-4.
1997: Leiguarda R C; Pramstaller P P; Merello M; Starkstein S; Lees A J; Marsden C D
Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
Brain : a journal of neurology 1997;120 ( Pt 1)():75-90.
1996: Nisbet A P; Eve D J; Kingsbury A E; Daniel S E; Marsden C D; Lees A J; Foster O J
Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Neuroscience 1996;75(2):389-406.
1996: Jendroska K; Lees A J; Poewe W; Daniel S E
Amyloid beta-peptide and the dementia of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1996;11(6):647-53.
1996: Turjanski N; Pirtosek Z; Quirk J; Anderson T J; Rivest J; Marsden C D; Lees A J
Botulinum toxin in the treatment of writer's cramp.
Clinical neuropharmacology 1996;19(4):314-20.
1996: Samuel M; Manford M; Sheean G; Lees A J
A neuromyotonic process in a transposed latissimus dorsi muscle stemming from radiotherapy and peripheral surgery.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):449-51.
1996: Quirk J A; Sheean G L; Marsden C D; Lees A J
Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
Movement disorders : official journal of the Movement Disorder Society 1996;11(4):377-83.
1996: Rascol O; Lees A J; Senard J M; Pirtosek Z; Montastruc J L; Fuell D
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
Clinical neuropharmacology 1996;19(3):234-45.
1996: Colosimo C; Merello M; Hughes A J; Sieradzan K; Lees A J
Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
Journal of neurology, neurosurgery, and psychiatry 1996;60(6):634-7.
1996: Pramstaller P P; Lees A J; Luxon L M
Possible clinical overlap between postencephalitic parkinsonism and progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1996;60(5):589-90.
1996: De Bruin V S; Machado C; Howard R S; Hirsch N P; Lees A J
Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).
Postgraduate medical journal 1996;72(847):293-6.
1996: Rascol O; Lees A J; Senard J M; Pirtosek Z; Brefel C; Montastruc J L; Fuell D
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
Advances in neurology 1996;69():531-4.
1996: Albanese A; Colosimo C; Lees A J; Tonali P
The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism.
Advances in neurology 1996;69():393-8.
1995: Lees A J
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
BMJ (Clinical research ed.) 1995;311(7020):1602-7.
1995: Sheean G L; Lees A J
Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
Journal of neurology, neurosurgery, and psychiatry 1995;59(6):601-7.
1995: de Yébenes J G; Sarasa J L; Daniel S E; Lees A J
Familial progressive supranuclear palsy. Description of a pedigree and review of the literature.
Brain : a journal of neurology 1995;118 ( Pt 5)():1095-103.
1995: Burn D J; Rinne J O; Quinn N P; Lees A J; Marsden C D; Brooks D J
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
Brain : a journal of neurology 1995;118 ( Pt 4)():951-8.
1995: Sieradzan K; Channon S; Ramponi C; Stern G M; Lees A J; Youdim M B
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease.
Journal of clinical psychopharmacology 1995;15(4 Suppl 2):51S-59S.
1995: Scolding N J; Smith S M; Sturman S; Brookes G B; Lees A J
Auctioneer's jaw: a case of occupational oromandibular hemidystonia.
Movement disorders : official journal of the Movement Disorder Society 1995;10(4):508-9.
1995: Revesz T; Daniel S E; Lees A J; Will R G
A case of progressive subcortical gliosis associated with deposition of abnormal prion protein (PrP)
Journal of neurology, neurosurgery, and psychiatry 1995;58(6):759-60.
1995: Davie C A; Pirtosek Z; Barker G J; Kingsley D P; Miller P H; Lees A J
Magnetic resonance spectroscopic study of parkinsonism related to boxing.
Journal of neurology, neurosurgery, and psychiatry 1995;58(6):688-91.
1995: Daniel S E; de Bruin V M; Lees A J
The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal.
Brain : a journal of neurology 1995;118 ( Pt 3)():759-70.
1995: Nisbet A P; Foster O J; Kingsbury A; Eve D J; Daniel S E; Marsden C D; Lees A J
Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Neuroscience 1995;66(2):361-76.
1995: Wenning G K; Shephard B; Hawkes C; Petruckevitch A; Lees A; Quinn N
Olfactory function in atypical parkinsonian syndromes.
Acta neurologica Scandinavica 1995;91(4):247-50.
1995: Colosimo C; Albanese A; Hughes A J; de Bruin V M; Lees A J
Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease.
Archives of neurology 1995;52(3):294-8.
1995: Markus H S; Lees A J; Lennox G; Marsden C D; Costa D C
Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):179-87.
1995: Kingsbury A E; Foster O J; Nisbet A P; Cairns N; Bray L; Eve D J; Lees A J; Marsden C D
Tissue pH as an indicator of mRNA preservation in human post-mortem brain.
Brain research. Molecular brain research 1995;28(2):311-8.
1994: Lees A J
The concept of bradyphrenia.
Revue neurologique 1994;150(12):823-6.
1994: Kempster P A; Lees A J
Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1994;57(11):1444.
1994: Spencer J P; Jenner A; Aruoma O I; Evans P J; Kaur H; Dexter D T; Jenner P; Lees A J; Marsden D C; Halliwell B
Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease.
FEBS letters 1994;353(3):246-50.
1994: Jendroska K; Hoffmann O; Schelosky L; Lees A J; Poewe W; Daniel S E
Absence of disease related prion protein in neurodegenerative disorders presenting with Parkinson's syndrome.
Journal of neurology, neurosurgery, and psychiatry 1994;57(10):1249-51.
1994: Sian J; Dexter D T; Lees A J; Daniel S; Jenner P; Marsden C D
Glutathione-related enzymes in brain in Parkinson's disease.
Annals of neurology 1994;36(3):356-61.
1994: Sian J; Dexter D T; Lees A J; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden C D
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Annals of neurology 1994;36(3):348-55.
1994: Jendroska K; Olasode B J; Daniel S E; Elliott L; Ogunniyi A O; Aghadiuno P U; Osuntokun B O; Lees A J
Incidental Lewy body disease in black Africans.
Lancet 1994;344(8926):882-3.
1994: De Bruin V M; Lees A J
Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):381-9.
1994: Scolding N J; Lees A J
Micrographia associated with a parietal lobe lesion in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1994;57(6):739-41.
1994: Turjanski N; Sawle G V; Playford E D; Weeks R; Lammerstma A A; Lees A J; Brooks D J
PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.
Journal of neurology, neurosurgery, and psychiatry 1994;57(6):688-92.
1994: Hughes A J; Frankel J P; Kempster P A; Stern G M; Lees A J
Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years.
Journal of neurology, neurosurgery, and psychiatry 1994;57(4):430-4.
1994: Tanner C M; Melamed E; Lees A J
Managing motor fluctuations, dyskinesias, and other adverse effects in Parkinson's disease.
Neurology 1994;44(3 Suppl 1):S12-6.
1994: Nisbet A P; Foster O J; Kingsbury A; Lees A J; Marsden C D
Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function.
Brain research. Molecular brain research 1994;22(1-4):329-32.
1994: Merello M; Lees A J; Webster R; Bovingdon M; Gordin A
Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1994;57(2):186-9.
1994: Markus H S; Costa D C; Lees A J
HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.
Journal of neurology, neurosurgery, and psychiatry 1994;57(2):180-5.
1994: Robbins T W; James M; Owen A M; Lange K W; Lees A J; Leigh P N; Marsden C D; Quinn N P; Summers B A
Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.
Journal of neurology, neurosurgery, and psychiatry 1994;57(1):79-88.
1994: Dexter D T; Sian J; Rose S; Hindmarsh J G; Mann V M; Cooper J M; Wells F R; Daniel S E; Lees A J; Schapira A H
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Annals of neurology 1994;35(1):38-44.
1994: Dexter D T; Holley A E; Flitter W D; Slater T F; Wells F R; Daniel S E; Lees A J; Jenner P; Marsden C D
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):92-7.
1994: Rothwell J C; Vidailhet M; Thompson P D; Lees A J; Marsden C D
The auditory startle response in progressive supranuclear palsy.
Journal of neural transmission. Supplementum 1994;42():43-50.
1993: de Bruin P F; de Bruin V M; Lees A J; Pride N B
Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease.
The American review of respiratory disease 1993;148(6 Pt 1):1576-80.
1993: Sawle G V; Lees A J; Hymas N F; Brooks D J; Frackowiak R S
The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome.
Journal of neurology, neurosurgery, and psychiatry 1993;56(9):1016-9.
1993: Turjanski N; Fernandez W; Lees A J
The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1993;56(7):771-5.
1993: Hughes A J; Bishop S; Kleedorfer B; Turjanski N; Fernandez W; Lees A J; Stern G M
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):165-70.
1993: Geddes J F; Hughes A J; Lees A J; Daniel S E
Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex.
Brain : a journal of neurology 1993;116 ( Pt 1)():281-302.
1993: Hughes A J; Daniel S E; Blankson S; Lees A J
A clinicopathologic study of 100 cases of Parkinson's disease.
Archives of neurology 1993;50(2):140-8.
1993: Lees A J
Dopamine agonists in Parkinson's disease: a look at apomorphine.
Fundamental & clinical pharmacology 1993;7(3-4):121-8.
1993: Hughes A J; Daniel S E; Lees A J
The clinical features of Parkinson's disease in 100 histologically proven cases.
Advances in neurology 1993;60():595-9.
1993: Daniel S E; Lees A J
Parkinson's Disease Society Brain Bank, London: overview and research.
Journal of neural transmission. Supplementum 1993;39():165-72.
1992: Jenkins I H; Fernandez W; Playford E D; Lees A J; Frackowiak R S; Passingham R E; Brooks D J
Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.
Annals of neurology 1992;32(6):749-57.
1992: Merello M; Lees A J
Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(11):1024-6.
1992: Hughes A J; Colosimo C; Kleedorfer B; Daniel S E; Lees A J
The dopaminergic response in multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 1992;55(11):1009-13.
1992: Sawle G V; Wroe S J; Lees A J; Brooks D J; Frackowiak R S
The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred.
Annals of neurology 1992;32(5):609-17.
1992: de Bruin V M; Lees A J; Daniel S E
Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report.
Movement disorders : official journal of the Movement Disorder Society 1992;7(4):355-8.
1992: Dexter D T; Ward R J; Wells F R; Daniel S E; Lees A J; Peters T J; Jenner P; Marsden C D
Alpha-tocopherol levels in brain are not altered in Parkinson's disease.
Annals of neurology 1992;32(4):591-3.
1992: Vidailhet M; Rothwell J C; Thompson P D; Lees A J; Marsden C D
The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease.
Brain : a journal of neurology 1992;115 ( Pt 4)():1181-92.
1992: Merello M; Pirtosek Z; Bishop S; Lees A J
Cardiovascular reflexes in Parkinson's disease: effect of domperidone and apomorphine.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1992;2(4):215-9.
1992: Quinn N; Daniel S; Magalhães-Branco M; Lees A; Hughes A
Lack of pyramidal tract signs in Parkinson's disease.
Lancet 1992;340(8811):125.
1992: Hughes A J; Ben-Shlomo Y; Daniel S E; Lees A J
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.
Neurology 1992;42(6):1142-6.
1992: Turjanski N; Lees A J
Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(5):413.
1992: Hughes A J; Daniel S E; Kilford L; Lees A J
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
Journal of neurology, neurosurgery, and psychiatry 1992;55(3):181-4.
1992: Brooks D J; Ibanez V; Sawle G V; Playford E D; Quinn N; Mathias C J; Lees A J; Marsden C D; Bannister R; Frackowiak R S
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Annals of neurology 1992;31(2):184-92.
1992: Lees A J; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G
Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.
Journal of neurology 1992;239(1):1-4.
1992: Fernandez W; Lees A J
Temporary deterioration in parkinsonian signs after modest alcohol intake.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):284-5.
1992: Lees A J
When did Ray Kennedy's Parkinson's disease begin?
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):110-6.
1992: Emre M; Rinne U K; Rascol A; Lees A; Agid Y; Lataste X
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Movement disorders : official journal of the Movement Disorder Society 1992;7(3):239-43.
1992: Brooks D J; Turjanski N; Sawle G V; Playford E D; Lees A J
PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome.
Advances in neurology 1992;58():227-31.
1991: Hughes A J; Webster R; Bovingdon M; Lees A J; Stern G M
Sublingual apomorphine in the treatment of Parkinson's disease complicated by motor fluctuations.
Clinical neuropharmacology 1991;14(6):556-61.
1991: Hughes A J; Lees A J; Stern G M
Challenge tests to predict the dopaminergic response in untreated Parkinson's disease.
Neurology 1991;41(11):1723-5.
1991: Daniel S E; Lees A J
Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
Journal of neurology, neurosurgery, and psychiatry 1991;54(11):972-5.
1991: Fearnley J M; Lees A J
Ageing and Parkinson's disease: substantia nigra regional selectivity.
Brain : a journal of neurology 1991;114 ( Pt 5)():2283-301.
1991: Sawle G V; Hymas N F; Lees A J; Frackowiak R S
Obsessional slowness. Functional studies with positron emission tomography.
Brain : a journal of neurology 1991;114 ( Pt 5)():2191-202.
1991: Montastruc J L; Rascol O; Senard J M; Gualano V; Bagheri H; Houin G; Lees A; Rascol A
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1991;14(5):432-7.
1991: Kleedorfer B; Stern G M; Lees A J; Bottomley J M; Sree-Haran N
Ropinirole (SK and F 101468) in the treatment of Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1991;54(10):938.
1991: Dexter D T; Carayon A; Javoy-Agid F; Agid Y; Wells F R; Daniel S E; Lees A J; Jenner P; Marsden C D
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Brain : a journal of neurology 1991;114 ( Pt 4)():1953-75.
1991: Sawle G V; Leenders K L; Brooks D J; Harwood G; Lees A J; Frackowiak R S; Marsden C D
Dopa-responsive dystonia: [18F]dopa positron emission tomography.
Annals of neurology 1991;30(1):24-30.
1991: Hughes A J; Bishop S; Stern G M; Lees A J
The motor response to repeated apomorphine administration in Parkinson's disease.
Clinical neuropharmacology 1991;14(3):209-13.
1991: Gibb W R; Narabayashi H; Yokochi M; Iizuka R; Lees A J
New pathologic observations in juvenile onset parkinsonism with dystonia.
Neurology 1991;41(6):820-2.
1991: Kleedorfer B; Turjanski N; Ryan R; Lees A J; Milroy C; Stern G M
Intranasal apomorphine in Parkinson's disease.
Neurology 1991;41(5):761-2.
1991: Burn D J; Ball J; Lees A J; Behan P O; Morgan-Hughes J A
A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid decarboxylase antibodies [corrected]
Journal of neurology, neurosurgery, and psychiatry 1991;54(5):449-51.
1991: Gibb W R; Lees A J
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1991;54(5):388-96.
1991: Kleedorfer B; Lees A J; Stern G M
Buspirone in the treatment of levodopa induced dyskinesias.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):376-7.
1991: Kleedorfer B; Lees A J; Stern G M
Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):373.
1991: Hughes A J; Lees A J; Stern G M
The motor response to sequential apomorphine in parkinsonian fluctuations.
Journal of neurology, neurosurgery, and psychiatry 1991;54(4):358-60.
1991: Fearnley J M; Revesz T; Brooks D J; Frackowiak R S; Lees A J
Diffuse Lewy body disease presenting with a supranuclear gaze palsy.
Journal of neurology, neurosurgery, and psychiatry 1991;54(2):159-61.
1991: Fish D R; Sawyers D; Allen P J; Blackie J D; Lees A J; Marsden C D
The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia.
Archives of neurology 1991;48(2):210-4.
1991: Hughes A J; Bishop S; Lees A J; Stern G M; Webster R; Bovingdon M
Rectal apomorphine in Parkinson's disease.
Lancet 1991;337(8733):118.
1991: Hughes A J; Lees A J; Marsden C D
Paroxysmal dystonic head tremor.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):85-6.
1991: Rivest J; Lees A J; Marsden C D
Writer's cramp: treatment with botulinum toxin injections.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):55-9.
1991: Gibb W R; Scott T; Lees A J
Neuronal inclusions of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1991;6(1):2-11.
1991: Lees A J
Selegiline hydrochloride and cognition.
Acta neurologica Scandinavica. Supplementum 1991;136():91-4.
1991: Hughes A J; Daniel S E; Lees A J
Idiopathic Parkinson's disease combined with multiple system atrophy. A clinicopathological report.
Movement disorders : official journal of the Movement Disorder Society 1991;6(4):342-6.
1990: Fearnley J M; Lees A J
Striatonigral degeneration. A clinicopathological study.
Brain : a journal of neurology 1990;113 ( Pt 6)():1823-42.
1990: Frankel J P; Pirtosek Z; Kempster P A; Bovingdon M; Webster R; Lees A J; Stern G M
Diurnal differences in response to oral levodopa.
Journal of neurology, neurosurgery, and psychiatry 1990;53(11):948-50.
1990: Kapoor R; Turjanski N; Frankel J; Kleedorfer B; Lees A; Stern G; Bovingdon M; Webster R
Intranasal apomorphine: a new treatment in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1990;53(11):1015.
1990: Kempster P A; Frankel J P; Stern G M; Lees A J
Comparison of motor response to apomorphine and levodopa in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1990;53(11):1004-7.
1990: Brooks D J; Ibanez V; Sawle G V; Quinn N; Lees A J; Mathias C J; Bannister R; Marsden C D; Frackowiak R S
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Annals of neurology 1990;28(4):547-55.
1990: Thompson A J; Smith I; Brenton D; Youl B D; Rylance G; Davidson D C; Kendall B; Lees A J
Neurological deterioration in young adults with phenylketonuria.
Lancet 1990;336(8715):602-5.
1990: Hughes A J; Lees A J; Stern G M
Apomorphine in the diagnosis and treatment of parkinsonian tremor.
Clinical neuropharmacology 1990;13(4):312-7.
1990: Dexter D T; Carayon A; Vidailhet M; Ruberg M; Agid F; Agid Y; Lees A J; Wells F R; Jenner P; Marsden C D
Decreased ferritin levels in brain in Parkinson's disease.
Journal of neurochemistry 1990;55(1):16-20.
1990: Hughes A J; Lees A J; Stern G M
Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes.
Lancet 1990;336(8706):32-4.
1990: Frankel J P; Hughes A; Lees A J; Stern G M
Marijuana for parkinsonian tremor.
Journal of neurology, neurosurgery, and psychiatry 1990;53(5):436.
1990: Frankel J P; Lees A J; Kempster P A; Stern G M
Subcutaneous apomorphine in the treatment of Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1990;53(2):96-101.
1990: Lees A J
Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease.
Advances in neurology 1990;53():475-82.
1990: Eatough V M; Kempster P A; Stern G M; Lees A J
Premorbid personality and idiopathic Parkinson's disease.
Advances in neurology 1990;53():335-7.
1990: Gibb W R; Mann D M; Mountjoy C Q; Lees A J
A pathological study of the association between Lewy body disease and Alzheimer's disease.
Advances in neurology 1990;53():55-9.
1990: Gibb W R; Fearnley J M; Lees A J
The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
Advances in neurology 1990;53():31-4.
1990: Iliceto G; Thompson P D; Day B L; Rothwell J C; Lees A J; Marsden C D
Diaphragmatic flutter, the moving umbilicus syndrome, and "belly dancer's" dyskinesia.
Movement disorders : official journal of the Movement Disorder Society 1990;5(1):15-22.
1990: Turjanski N; Lees A J
[Apomorphine in the treatment of Parkinson's disease]
Medicina 1990;50(4):365-8.
1990: Eatough V M; Kempster P A; Frankel J P; Curry S H; Rogers D; Lees A J; Stern G M
Effects of L-deprenyl on parkinsonian bradyphrenia.
Advances in neurology 1990;53():441-3.
1989: Lees A J; Montastruc J L; Turjanski N; Rascol O; Kleedorfer B; Peyro Saint-Paul H; Stern G M; Rascol A
Sublingual apomorphine and Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(12):1440.
1989: Lees A J
Transplantation in Parkinson's disease.
British journal of hospital medicine 1989;42(4):261, 263.
1989: Mathers S E; Kempster P A; Law P J; Frankel J P; Bartram C I; Lees A J; Stern G M; Swash M
Anal sphincter dysfunction in Parkinson's disease.
Archives of neurology 1989;46(10):1061-4.
1989: Frankel J P; Kempster P A; Stibe C M; Eatough V M; Nathanson M; Lees A J; Stern G M
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease.
Clinical neuropharmacology 1989;12(5):448-51.
1989: Frankel J P; Kempster P A; Bovingdon M; Webster R; Lees A J; Stern G M
The effects of oral protein on the absorption of intraduodenal levodopa and motor performance.
Journal of neurology, neurosurgery, and psychiatry 1989;52(9):1063-7.
1989: Saggu H; Cooksey J; Dexter D; Wells F R; Lees A; Jenner P; Marsden C D
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.
Journal of neurochemistry 1989;53(3):692-7.
1989: Frankel J P; Hughes A; Lees A J; Stern G M; Walshe J M
Use of apomorphine to test for dopamine responsiveness in Wilson's disease.
Lancet 1989;2(8666):801-2.
1989: Dexter D T; Wells F R; Lees A J; Agid F; Agid Y; Jenner P; Marsden C D
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
Journal of neurochemistry 1989;52(6):1830-6.
1989: Lees A J
The on-off phenomenon.
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():29-37.
1989: Kapoon R; Pirtosek Z; Frankel J P; Stern G M; Lees A J; Bottomley J M; Haran N S
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468.
Lancet 1989;1(8652):1445-6.
1989: Gibb W R; Mountjoy C Q; Mann D M; Lees A J
A pathological study of the association between Lewy body disease and Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):701-8.
1989: Kempster P A; Frankel J P; Bovingdon M; Webster R; Lees A J; Stern G M
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):718-23.
1989: Barker R; Duncan J; Lees A
Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes.
Lancet 1989;1(8639):675.
1989: Dexter D T; Carter C J; Wells F R; Javoy-Agid F; Agid Y; Lees A; Jenner P; Marsden C D
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Journal of neurochemistry 1989;52(2):381-9.
1989: Lees A J
[Neuropsychological disorders in Parkinson disease. Relations to psychomotor inhibition and obsessive-compulsive disease]
Der Nervenarzt 1989;60(2):71-9.
1989: Gibb W R; Mountjoy C Q; Mann D M; Lees A J
The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.
Journal of neurology, neurosurgery, and psychiatry 1989;52(2):193-200.
1989: Kempster P A; Gibb W R; Stern G M; Lees A J
Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations.
Journal of neurology, neurosurgery, and psychiatry 1989;52(1):72-6.
1989: Gibb W R; Lees A J
The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease.
Neuropathology and applied neurobiology 1989;15(1):27-44.
1989: Kempster P A; Lees A J; Crichton P; Frankel J P; Shorvon P
Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine.
Movement disorders : official journal of the Movement Disorder Society 1989;4(1):47-52.
1989: Lees A J; Frankel J; Eatough V; Stern G M
New approaches in the use of selegiline for the treatment of Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1989;126():139-45.
1989: Gibb W R; Terruli M; Lees A J; Jenner P; Marsden C D
The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Movement disorders : official journal of the Movement Disorder Society 1989;4(1):53-74.
1988: Lees A J; Blackburn N A; Campbell V L
The nighttime problems of Parkinson's disease.
Clinical neuropharmacology 1988;11(6):512-9.
1988: Mathers S E; Kempster P A; Swash M; Lees A J
Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon?
Journal of neurology, neurosurgery, and psychiatry 1988;51(12):1503-7.
1988: Christmas T J; Kempster P A; Chapple C R; Frankel J P; Lees A J; Stern G M; Milroy E J
Role of subcutaneous apomorphine in parkinsonian voiding dysfunction.
Lancet 1988;2(8626-8627):1451-3.
1988: Gibb W R; Lees A J
A comparison of clinical and pathological features of young- and old-onset Parkinson's disease.
Neurology 1988;38(9):1402-6.
1988: Will R G; Lees A J; Gibb W; Barnard R O
A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome.
Journal of neurology, neurosurgery, and psychiatry 1988;51(9):1224-7.
1988: Uney J B; Leigh P N; Marsden C D; Lees A; Anderton B H
Stereotaxic injection of kainic acid into the striatum of rats induces synthesis of mRNA for heat shock protein 70.
FEBS letters 1988;235(1-2):215-8.
1988: Leenders K L; Frackowiak R S; Lees A J
Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography.
Brain : a journal of neurology 1988;111 ( Pt 3)():615-30.
1988: Hardie R J; Lees A J
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Journal of neurology, neurosurgery, and psychiatry 1988;51(6):850-4.
1988: Gibb W R; Lees A J
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1988;51(6):745-52.
1988: Calne D B; Lees A J
Late progression of post-encephalitic Parkinson's syndrome.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1988;15(2):135-8.
1988: Stibe C M; Lees A J; Kempster P A; Stern G M
Subcutaneous apomorphine in parkinsonian on-off oscillations.
Lancet 1988;1(8582):403-6.
1988: Poewe W H; Lees A J; Stern G M
Dystonia in Parkinson's disease: clinical and pharmacological features.
Annals of neurology 1988;23(1):73-8.
1988: Lees A J
Facial mannerisms and tics.
Advances in neurology 1988;49():255-61.
1988: Gibb W R; Lees A J; Marsden C D
Pathological report of four patients presenting with cranial dystonias.
Movement disorders : official journal of the Movement Disorder Society 1988;3(3):211-21.
1987: Dexter D T; Wells F R; Agid F; Agid Y; Lees A J; Jenner P; Marsden C D
Increased nigral iron content in postmortem parkinsonian brain.
Lancet 1987;2(8569):1219-20.
1987: Gibb W R; Esiri M M; Lees A J
Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).
Brain : a journal of neurology 1987;110 ( Pt 5)():1131-53.
1987: Rogers D; Lees A J; Smith E; Trimble M; Stern G M
Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study.
Brain : a journal of neurology 1987;110 ( Pt 3)():761-76.
1987: Bihari K; Lees A J
Cigarette smoking, Parkinson's disease and ulcerative colitis.
Journal of neurology, neurosurgery, and psychiatry 1987;50(5):635.
1987: Wright A; Lees A J; Stern G M
Mesulergine and pergolide in previously untreated Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1987;50(4):482-4.
1987: Stibe C; Lees A; Stern G
Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.
Lancet 1987;1(8537):871.
1987: Hardie R J; Lees A J; Stern G M
Pharmacokinetics of levodopa and motor fluctuations.
Advances in neurology 1987;45():487-92.
1987: Rogers D; Lees A J; Trimble M; Stern G M
Concept of bradyphrenia: a neuropsychiatric approach.
Advances in neurology 1987;45():447-50.
1987: Poewe W; Lees A J; Steiger D; Stern G M
Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology.
Advances in neurology 1987;45():357-60.
1987: Gibb W R; Lees A J
The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome.
Acta neuropathologica 1987;73(2):195-201.
1987: Poewe W H; Lees A J
The pharmacology of foot dystonia in parkinsonism.
Clinical neuropharmacology 1987;10(1):47-56.
1987: Klein P; Lees A; Stern G
Consequences of chronic 5-hydroxy-tryptophan in parkinsonian instability of gait and balance and in other neurological disorders.
Advances in neurology 1987;45():603-4.
1987: Lees A J
A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease.
European neurology 1987;27 Suppl 1():126-34.
1987: Poewe W H; Lees A J; Stern G M
Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations.
European neurology 1987;27 Suppl 1():93-7.
1987: Lees A J
Current controversies in the use of selegiline hydrochloride.
Journal of neural transmission. Supplementum 1987;25():157-62.
1987: Stern G; Lees A
Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.
Advances in neurology 1987;45():525-7.
1987: Gibb W R; Lees A J; Wells F R; Barnard R O; Jenner P; Marsden C D
Pathology of MPTP in the marmoset.
Advances in neurology 1987;45():187-90.
1986: Poewe W H; Lees A J; Stern G M
Low-dose L-dopa therapy in Parkinson's disease: a 6-year follow-up study.
Neurology 1986;36(11):1528-30.
1986: Hardie R J; Malcolm S L; Lees A J; Stern G M; Allen J G
The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations.
British journal of clinical pharmacology 1986;22(4):429-36.
1986: Dexter D; Carter C; Agid F; Agid Y; Lees A J; Jenner P; Marsden C D
Lipid peroxidation as cause of nigral cell death in Parkinson's disease.
Lancet 1986;2(8507):639-40.
1986: Maher E R; Lees A J
The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).
Neurology 1986;36(7):1005-8.
1986: Lees A J
L-dopa treatment and Parkinson's disease.
The Quarterly journal of medicine 1986;59(230):535-47.
1986: Poewe W H; Lees A J; Stern G M
Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations.
Clinical neuropharmacology 1986;9(5):430-9.
1985: Kahn J; Anderton B H; Gibb W R; Lees A J; Wells F R; Marsden C D
Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
The New England journal of medicine 1985;313(8):520-1.
1985: Todes C J; Lees A J
The pre-morbid personality of patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1985;48(2):97-100.
1985: Lees A J
Parkinson's disease and dementia.
Lancet 1985;1(8419):43-4.
1985: Hardie R J; Lees A J; Stern G M
The controversial role of bromocriptine in Parkinson's disease.
Clinical neuropharmacology 1985;8(2):150-5.
1984: Jenner P; Rupniak N M; Rose S; Kelly E; Kilpatrick G; Lees A; Marsden C D
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
Neuroscience letters 1984;50(1-3):85-90.
1984: Lees A J; Hardie R J; Stern G M
Kinesigenic foot dystonia as a presenting feature of Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1984;47(8):885.
1984: Curtis L; Lees A J; Stern G M; Marmot M G
Effect of L-dopa on course of Parkinson's disease.
Lancet 1984;2(8396):211-2.
1984: Hardie R J; Lees A J; Stern G M
On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.
Brain : a journal of neurology 1984;107 ( Pt 2)():487-506.
1983: Hardie R J; Lees A J; Stern G M
Sustained levodopa therapy in tardive dyskinesia.
Journal of neurology, neurosurgery, and psychiatry 1983;46(7):685.
1983: Lees A J; Smith E
Cognitive deficits in the early stages of Parkinson's disease.
Brain : a journal of neurology 1983;106 (Pt 2)():257-70.
1983: Hardie R J; Lees A J; Stern G M
Levodopa induced chorea in Meige syndrome.
Journal of neurology, neurosurgery, and psychiatry 1983;46(3):286.
1983: Lees A J; Stern G M
Sustained low-dose levodopa therapy in Parkinson's disease: a 3-year follow-up.
Advances in neurology 1983;37():9-15.
1983: Stern G M; Lees A J
Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
Advances in neurology 1983;37():17-21.
1983: Glover V; Lees A J; Ward C; Stern G M; Sandler M
Platelet phenolsulphotransferase activity in Parkinson's disease.
Journal of neural transmission 1983;57(1-2):95-102.
1983: Stern G M; Lees A J; Hardie R J; Sandler M
Clinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1983;95():113-6.
1983: Stern G M; Lees A J; Hardie R; Sandler M
Clinical and pharmacological aspects of (-)-deprenyl treatment in Parkinson's disease.
Modern problems of pharmacopsychiatry 1983;19():215-9.
1982: Lees A J; Stern G M; Compston D A
Histocompatibility antigens and post-encephalitic Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1982;45(11):1060-1.
1982: Elsworth J D; Sandler M; Lees A J; Ward C; Stern G M
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties.
Journal of neural transmission 1982;54(1-2):105-10.
1981: Lees A J; Stern G M
Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1981;44(11):1020-3.
1981: Lees A J
Early diagnosis of Parkinson's disease.
British journal of hospital medicine 1981;26(5):511-2, 517-8.
1981: Lees A J; Stern G M
Pergolide and lisuride for levodopa-induced oscillations.
Lancet 1981;2(8246):577.
1980: Lees A J; Stern G M
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia.
Lancet 1980;2(8187):215-6.
1980: Shaw K M; Lees A J; Stern G M
The impact of treatment with levodopa on Parkinson's disease.
The Quarterly journal of medicine 1980;49(195):283-93.
1980: Stern G M; Lees A J; Shaw K M; Lander C M
The role of bromocriptine in the treatment of Parkinson's disease.
Advances in biochemical psychopharmacology 1980;23():267-70.
1980: Stern G M; Lander C M; Lees A J
Akinetic freezing and trick movements in Parkinson's disease.
Journal of neural transmission. Supplementum 1980;(16):137-41.
1979: Williams A; Houff S; Lees A; Calne D B
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1979;42(9):790-2.
1979: Lees A J; Lander C M; Stern G M
Tiapride in levodopa-induced involuntary movements.
Journal of neurology, neurosurgery, and psychiatry 1979;42(4):380-3.
1979: Bender D A; Earl C J; Lees A J
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
Clinical science (London, England : 1979) 1979;56(1):89-93.
1979: Lander C M; Lees A; Stern G
Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
Clinical and experimental neurology 1979;16():197-203.
1978: Stern G; Lees A
Bromocriptine in Parkinson's disease.
British journal of hospital medicine 1978;20(6):666-70.
1978: Lees A J; Lander C M; Stern G M
Tiapride and sulpiride in Parkinson's disease.
Lancet 1978;2(8101):1205.
1978: Lees A J; Haddad S; Shaw K M; Kohout L J; Stern G M
Bromocriptine in parkinsonism. A long-term study.
Archives of neurology 1978;35(8):503-5.
1978: Lees A J; Shaw K M; Stern G M
Baclofen in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1978;41(8):707-8.
1978: Stern G; Lees A
The on-off effect - a side-effect of long-term levodopa treatment.
Nursing mirror 1978;147(7):17-8.
1978: Shaw K M; Lees A J; Stern G M
Bromocriptine in Parkinson's disease.
Lancet 1978;1(8076):1255.
1978: Elsworth J D; Glover V; Reynolds G P; Sandler M; Lees A J; Phuapradit P; Shaw K M; Stern G M; Kumar P
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'.
Psychopharmacology 1978;57(1):33-8.
1978: Stern G M; Lees A J; Sandler M
Recent observations on the clinical pharmacology of (-)deprenyl.
Journal of neural transmission 1978;43(3-4):245-51.
1978: Shaw K M; Lees A J; Franks S; Daggett P; Thompson B D; Stern G M
Endocrine aspects of bromocriptine therapy in Parkinsonism.
Journal of neural transmission 1978;43(2):153-60.
1977: Lees A J; Shaw K M; Stern G M
"Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease.
Lancet 1977;2(8046):1034.
1977: Lees A J
Bromocriptine.
British journal of hospital medicine 1977;18(4):336, 341-2.
1977: Stern G M; Lees A J
Choice of treatment in Parkinson's disease.
The Practitioner 1977;219(1312):537-41.
1977: Lees A J; Shaw K M; Kohout L J; Stern G M; Elsworth J D; Sandler M; Youdim M B
Deprenyl in Parkinson's disease.
Lancet 1977;2(8042):791-5.
1977: Lees A J; Clarke C R; Harrison M J
Hallucinations after withdrawal of baclofen.
Lancet 1977;1(8016):858.
1976: Shaw K M; Lees A J; Hayes S; Ross E J; Stern G M; Thompson B D
Letter: Growth-hormone response to bromocriptine in parkinsonism.
Lancet 1976;1(7952):194.
1975: Lees A J; Shaw K M; Stern G M
Letter: Bromocriptine in parkinsonism.
Lancet 1975;2(7937):709-10.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Andrew Lees

Research Profile (preview)

Disorders

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Andrew Lees (preview)

All Publications